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ABSTRACT OF DISSERTATION

ELUCIDATING THE BIOCHEMICAL WIZARDRY OF
TRITERPENE METABOLISM IN BOTROYCOCCUS BRAUNII
B. braunii is a green alga that has attracted attention as a potential renewable
fuel source due to its high oil content and the archeological record of its unique
contribution to oil and coal shales. Three extant chemotypes of B. braunii have been
described, namely race A, race B, and race L, which accumulate alkadienes and
alkatrienes, botryococcene and squalene and their methylated derivatives, and
lycopadiene, respectively. The methylated triterpenes, particularly botryococcenes,
produced by race B can be efficiently converted to high quality combustible fuels and
other petrochemicals; however, botryococcene biosynthesis has remained enigmatic.
It has been suggested that botryococcene biosynthesis could resemble that of
squalene, arising from an initial condensation of two molecules of farnesyl diphosphate
(FPP) to form pre-squalene diphosphate (PSPP), which then undergoes a reductive
rearrangement to form squalene, or in an alternative reductive rearrangement,
botryococcene. Based on the proposed similarities, we predicted that a botryococcene
synthase would resemble squalene synthase and hence, isolated squalene synthaselike genes from B. braunii race B. While B. braunii does harbor at least one typical
squalene synthase, none of the other three squalene synthase-like (SSL) genes encode
for botryococcene biosynthesis directly. SSL-1 catalyzes the biosynthesis of PSPP and
SSL-2 the biosynthesis of bisfarnesyl ether and to a lesser extent squalene, while SSL-3
does not appear able to directly utilize FPP as a substrate. However, when SSL-1 is
combined with either SSL-2 or SSL-3, in vivo and in vitro, robust squalene or
botryococcene biosynthesis was observed, respectively.
These findings were
unexpected because squalene synthase, an ancient and likely progenitor to the other
Botryococcus triterpene synthases, catalyzes a two-step reaction within a single enzyme
unit without intermediate release, yet in B. braunii, these activities appear to have
separated and evolved inter-dependently for specialized triterpene production.
Expression of various configurations of the SSL genes in TN-7 yeast demonstrates that
botryococcene can be efficiently produced in a heterologous host.
Additionally, three triterpene methyltransferase (TMTs) were isolated which
efficiently catalyze the transfer of a methyl group from S-adenosyl methionine (SAM) to
either squalene (TMT-1 and TMT-2) or botryococcene (TMT-3) in vivo and in vitro. Coii

expression of the various TMT genes with either squalene synthase or botryococcene
synthase in TN-7 yeast resulted in the accumulation of C31 and C32 methyl derivatives of
squalene or botryococcene, demonstrating their potential for heterologous production.
The methylation sites were determined by NMR spectroscopy to be identical to C31 and
C32 methyl-derivatives of squalene or botryococcene observed in B. braunii race B.
Expression studies of various heterologous squalene synthase genes in S.
cerevisiae corroborated an earlier but surprising observation reported in the literature.
While the squalene synthase gene of S. cerevisiae was able to complement an erg9
(squalene synthase) knockout in yeast, squalene synthase genes from plants and
animals were not. Chemical profiles revealed that squalene accumulated to significant
levels in yeast expressing the squalene synthase of plant, animal, or S. cerevisiae. This
suggested that it was not the ability of these heterologous synthase enzymes to produce
squalene, but their inability to feed squalene into the native sterol biosynthetic pathway
that prevented them from restoring normal ergosterol biosynthesis in S. cerevisiae. By
examining the ability of chimera squalene synthase enzymes to complement the erg9
mutation, a discrete sequence of amino acids near the C-terminus of the enzyme was
identified which is necessary and sufficient for allowing any squalene synthase to restore
normal sterol metabolism.

KEYWORDS: Botryococcus braunii, Botryococcene, Squalene, Bisfarnesyl Ether,
Triterpene Methyl-Transferase, erg9 complementation
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Chapter 1 Background and Introduction

Background and Introduction
Botryococcus braunii is an interesting algal species that dates back at least 500 million
years ago (Figure 1.1). The earliest evidence of B. braunii are found in sedimentary
basins in Australia and date to the Precambrian era (1), and its fossil and chemical
remains have been observed in oil shales around the world dating from the Precambrian
to as recently as the Pliocene era (2). Aside from oil shales, B. braunii remains have
been discovered in Kentucky coal beds produced during the Carboniferous era (3). In
some cases, B. braunii oils appear to have contributed as much as 1.4% to the total
hydrocarbons in oil shales (4); thus, B. braunii is recognized as a major contributor to oil
and coal deposits throughout geological time.
Another interesting aspect of B. braunii is that three extant races (chemotypes) of this
alga have been documented that differ in the type of oil that each accumulates (Figure
1.2). Race A accumulates C23-C27 alkadienes and alkatrienes which are fatty acid or
polyketide derived compounds (5). Race B accumulates the C30 triterpenes, squalene
and botryococcene, and their methylated derivates (6). Race L accumulates the
tetraterpene, lycopadiene (7). All races are morphologically similar, consisting of single
oblong-shaped cells that form colonies ranging from four to several tens of cells held
together by an extracellular matrix (Figure 1.3). Oil accumulates in both intracellular oil
bodies and in association with the extracellular matrix (Figure 1.3) (8). The major
metabolites of each race of B. braunii are unusual compounds in that they are only
known to be produced by their respective race of B. braunii. Thus, these chemicals
have been used as markers indicating the presence of B. braunii in oil and coal shale
deposits around the world (9).
While the different races share physical and
morphological similarities to one another, little is actually known about their biochemical
and genetic similarities and differences. For instance, is each of the races equally
capable of producing all three kinds of oils? And, if so, is there a genetic, biochemical,
environmental or some other factor that determines what class of oils a particular race
will accumulate?

1

Figure 1.1 B. braunii is a major contributor to coal and petroleum shale deposits
throughout geological time.
The left-hand panel reflects a timescale for geological events and biological evolution
(plants, far left; animals on the right) on Earth. The timeline is further annotated (red,
blue and green) for reports of petroleum and coal deposits sampled, dated, and
analyzed for fossil evidence (scanning and transmission micrographs) and chemical
profiling (GC chromatograph) document the prior existence of Botryococcus in these
sediments.

2

Figure 1.2 Three extant chemotypes of B. braunii are described.
Race A accumulates alkadienes and alkatrienes; race B accumulates botryococcene,
squalene, and their methylated derivatives (methylation sites indicated with green
circles); and race L accumulates lycopadiene.

3

Figure 1.3 Real-color light micrographs of B. braunii Race B.
The micrographs illustrate the clustering of cells held together by an extracellular matrix.
Photos courtesy of Tim Devarrene, Texas A&M University.
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Another reason B. braunii has attracted significant attention is because all three races
accumulate excessive amounts of oil ranging from 30 to 86% of their dry weight (10). Oil
levels of 30-40% dry weight are more commonly observed in races A and B grown in the
Chappell laboratory. The high levels of oil that accumulate in the algae cause it to float
in calm water (Figure 1.4), which might represent an ecological adaptation. Unlike most
algae, B. braunii do not have flagella, which enable other algae to swim towards light or
nutrients. The accumulating oil may serve to help B. braunii float to the top of ponds or
lakes where it can compete for resources such as light. A practical consequence of B.
braunii’s ability to float is that it would facilitate collection of the algae if grown on an
industrial scale. However, B. braunii grows considerably slower than most algae, and
the doubling time for B. braunii is about six days in comparison to C. reinhardtii that
doubles in as little as 5-8 hours (11). Figure 1.5 shows a side-by-side comparison of
these two algal species grown under identical conditions and clearly indicates the
difficulty of growing Botryococcus braunii rapidly on a large scale.
The oils of B. braunii, particularly Race B, are excellent feed stocks for the generation of
high octane fuels for combustion engines (12) as well as the building materials for the
industrial chemistry sector; however, the slow growing nature of B. braunii limits its utility
as a production platform for the biosynthesis of such compounds. Capturing the genetic
blueprints for botryococcene biosynthesis would allow this pathway to be engineered
into faster growing organisms more suitable for large scale oil production.
Squalene biosynthesis is well described (13, 14, 15) whereas botryococcene
biosynthesis has remained elusive. It has been shown that botryococcene is derived
from the precursor, FPP (16), and it was proposed that botryococcene biosynthesis
could mirror that of squalene in that 2 FPPs are condensed into a pre-squalene
diphosphate intermediate that is reductively rearranged into either squalene or
botryococcene (17, 18). Botryococcene and squalene are further metabolized to C31-C37
methyl derivates, putatively through the action of SAM-dependent methyltransferases
(19). Botryococcene and its methyl-derivatives accumulate as hydrocarbon oil in both
intra- and extracellular compartments. Squalene and its methyl-derivatives accumulate
as a small proportion of the total hydrocarbon oil (less than 5% w/w) but are more
commonly incorporated into a variety of natural products such as carotenoid-like
compounds (20) or polymerized into an extracellular matrix (21). Figure 1.6 shows a
schematic representation of some of the unique biochemistry in B. braunii race B.

5

Figure 1.4 B. braunii floats in calm water.
B. braunii race B was grown in 1 liter Roux flasks aerated with 2.5% CO2 in air. The air
was turned off and photographs were taken at the indicated times.

6

Figure 1.5 Growth comparision of B. braunii and C. reinhardtii.
Cultures of B. braunii and C. reinhardtii were used to inoculate 500 mL of Chu13 media
and the algae was grown side-by-side in a fluorescent light bank and aerated with 2.5%
CO2 in air. Photographs were taken every 24 h to compare the growth of the two algal
species.
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Can we capture the genetic blueprints
for this unique biochemistry and then
deploy it into alternative, high
yielding platforms
Hydrocarbon pool

?

C30 Botryococcene

Farnesyl diphosphate

Botryococcenes

Squalene

Tetramethylsqualene

Squalene epoxides

Fatty acids

Polyaldehydes

Botryoxanthins
Braunixanthins
Resistant biopolymer

Figure 1.6 Predicted triterpene metabolism in B. braunii.
FPP is the precursor to the triterpenes, botryococcene and squalene, which are
subsequently methylated to primarily C32 and C34 derivatives. Triterpene oils accumulate
in intracellular oil bodies (cell colored as green and orange) and in an extracellular matrix
(colored yellow). Squalene and its methyl-derivatives are also incorporated into a variety
of natural products, such as the carotenoid-like compounds, botryoxanthins, and
braunixanthins, and also polymerized along with polyaldehydes into a resistant
extracellular matrix.
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One difficulty in characterizing triterpene synthase genes, such as squalene synthase, is
that many of these enzymes contain membrane-spanning domains that limit their
expression in E. coli. An alternative to bacterial expression is characterization of these
enzymes in a eukaryotic host that contains membrane systems, such as yeast. The
Chappell laboratory has used a yeast line, Cali-7, to characterize sesquiterpene
synthases (22). Cali-7 is an engineered yeast line that overproduces FPP, the precursor
to sesquiterpenes and triterpenes, by having its endogenous erg9 (squalene synthase)
knocked out and overexpression of HMGR, the rate limiting step in the MVA pathway.
To create a yeast line specific for triterpene expression, Cali-7 was modified by knocking
out its endogenous erg1 (squalene epoxidase), resulting in yeast line TN-7. TN-7 has
the ability to overproduce FPP, but is unable to metabolize squalene and is well suited
for triterpene synthase characterization. Not only does characterization of triterpene
synthase enzymes in TN-7 supplant bacterial expression systems, but also it allows for
the production and purification of mg quantities of product which enables structural
determination of the enzyme catalyzed molecule(s).

Experimental Aims of this Thesis
B. braunii has been studied extensively for several decades, but the biosynthesis of
botryococcene has remained enigmatic (16). Chapter Two describes efforts to elucidate
this biosynthetic pathway and provides an example of how the resulting genetic
blueprints can be used to engineer this unique metabolism into other host species. The
discovery that botryococcene and squalene biosynthesis occur by unique mechanisms
not observed in any other organisms to date, and chapter 4 provides preliminary
enzymological studies defining reaction conditions and co-factor requirements for
several of these interesting enzymes.
Chapter 2 explores the mechanism responsible for botryococcene biosynthesis in B.
braunii. The majority of the oil is composed of its C31 to C34 methylated-derivatives.
Methylated squalenes are also found into a variety of B. braunii natural products such as
those polymerized into the extracellular matrix, as a small component of the oil itself, and
carotenoid-like compounds. The methylation of botryococcene and squalene are
important physiological processes in B. braunii.
Methylated botryococcene and
squalene are also superior starting materials for the hydrocracking process and provide
for superior yields of combustible fuels (23). Chapter 4 describes efforts along with Scott
Kinison in the Chappell laboratory to identify and to functionally characterize the
triterpene methyltransferase enzymes (TMTs) of B. braunii.
Because these studies of algal triterpene synthases involved contrast and comparative
studies with other squalene synthases, this work included co-expression studies of
heterologous squalene synthases genes in S. cerevisiae and corroborated an earlier, but
surprising observation reported in the literature. While the squalene synthase gene of S.
cerevisiae was able to complement an erg9 (squalene synthase) knockout in yeast,
9

squalene synthases genes from plants and animals were not. A surprising observation
was that while expression of these other squalene squalene genes in yeast were not
able to complement the erg9 knockout (i.e., restore normal sterol metabolism), the yeast
efficiently produced and accumulated squalene. This suggested that it was not the
ability of these heterologous synthase enzymes to produce squalene, but their inability to
feed squalene into the native sterol biosynthetic pathway that prevented them from
restoring normal ergosterol biosynthesis in S. cerevisiae. Chapter 5 describes the work
which defines a discrete sequence of amino acids within the yeast squalene synthase
enzyme that are necessary and sufficient for allowing any squalene synthase to restore
normal sterol metabolism in the erg9 genetic background.

Copyright © Thomas D Niehaus 2011
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Chapter 2 Identification of unique mechanisms for triterpene biosynthesis in
Botryococcus braunii

Introduction
Botryococcene biosynthesis resembles that of squalene, a metabolite essential for sterol
metabolism in all eukaryotes.
Squalene arises from an initial condensation of two
molecules of farnesyl diphosphate (FPP) to form pre-squalene diphosphate (PSPP),
which undergoes a reductive rearrangement to form squalene. In principle,
botryococcene could arise from an alternative rearrangement of the pre-squalene
intermediate. Because of these similarities, we predicted that a botryococcene synthase
would resemble squalene synthase and hence isolated squalene synthase-like genes
from B. braunii race B. While B. braunii does harbor at least one typical squalene
synthase, none of the other three squalene synthase-like (SSL) genes encode for
botryococcene biosynthesis directly. SSL-1 catalyzes the biosynthesis of PSPP and
SSL-2 the biosynthesis of bisfarnesyl ether, while SSL-3 does not appear able to directly
utilize FPP as a substrate. When combinations of the synthase-like enzymes were
mixed together, in vivo and in vitro, robust botryococcene (SSL-1+SSL-3) or squalene
biosynthesis (SSL1+SSL-2) was observed. These findings were unexpected because
squalene synthase, an ancient and likely progenitor to the other Botryococcus triterpene
synthases, catalyzes a two-step reaction within a single enzyme unit without
intermediate release, yet in B. braunii, these activities appear to have separated and
evolved interdependently for specialized triterpene oil production greater than 500 MYA.
Co-expression of the SSL-1 and SSL-3 genes in different configurations, as independent
genes, as gene fusions, or targeted to intracellular membranes, demonstrates the
potential for engineering even greater efficiencies of botryococcene biosynthesis.

11

Background
Botryococcus braunii is a colony-forming, freshwater green algae reported to accumulate
30 to 86% of its dry weight as hydrocarbon oils (10). Three distinct races of B. braunii
have been described based on the types of hydrocarbons that each accumulates (24).
Race A accumulates fatty acid-derived alkadienes and alkatrienes (5); race L
accumulates the tetraterpene lycopadiene (7); and race B accumulates triterpenes,
predominately botryococcene, squalene, and their methylated derivatives (6). The oils
accumulate both in intracellular oil bodies and in association with an extracellular matrix
(8), which in race B consists largely of long-chain, cross-linked biopolymers formed in
part from acetalization of polymethylsqualene diols (21). Di- and tetra-methylated
botryococcenes are generally the most abundant triterpenes accumulating in race B with
reduced amounts of tetramethylated-squalene (25) and other structural derivatives of
squalene and botryococcene that range from C31 to C37 accumulating to various levels in
different strains and in response to variable culture conditions (26). Other
polymethylated derivatives such as diepoxy-tetramethylsqualene (27), botryolins (28),
and brauixanthins (20) have also been reported.
B. braunii race B has received significant attention because it is considered an ancient
algal species dating back at least 500 MYA and is one of the few organisms known to
have directly contributed to the existing oil and coal shale deposits found on Earth (1-3),
accounting for up to 1.4% of the total hydrocarbon content in oil shales (29). Secondly,
because the hydrocarbon oils of B. braunii race B are readily converted to starting
materials for industrial chemical manufacturing and high quality fuels under standard
hydrocracking/distillation conditions in yields approaching 97% (Figure 2.1A) (12), race B
has been considered a potential production host for renewable petrochemicals and
biofuels. Unfortunately, the slow growth habit of B. braunii poses serious limitations to
its suitability as a robust biofuel production system. Capture of the genes coding for this
unique oil biosynthetic capacity would provide opportunities to engineer this metabolism
into other faster growing and potentially higher yielding organisms (19) than B. braunii.
Our approach for identifying the triterpene biosynthetic genes in B. braunii relied in large
part on the putative similarities in the biosynthetic mechanisms for squalene and
botryococcene (17-18, 30). Squalene biosynthesis has been extensively investigated
because it is positioned at a putative branch point in the isoprenoid biosynthetic pathway
directing carbon flux to sterol metabolism, and thus represents a potential control point
for cholesterol biosynthesis in man (31). Evidence for a two-step reaction mechanism
catalyzed by squalene synthase has been described (13) (Figure 2.1B). The initial
reaction step consists of a head-to-head condensation of two farnesyl diphosphate
(FPP) molecules to form a stable cyclopropyl intermediate, pre-squalene diphosphate
(PSPP) (14, 32). In the second step, PSPP undergoes a reductive rearrangement in the
presence of NADPH to yield squalene possessing a C1-C1’ linkage between the two
farnesyl substituents (15, 33) (Figure 2.1B). Poulter (13) suggested that botryococcene
biosynthesis occurs via an analogous reaction mechanism with the initial reaction
12

Figure 2.1 The triterpene oils of B. braunii Race B and their putative biosynthetic
mechanism.
The triterpene oils of B. braunii race B (illustrated as tetramethyl-botryococcene) are
likely progenitors to existing coal and oil shale deposits according to geochemical and
fossil records (54). These oils are readily converted under standard hydrocracking
processes to molecular species of direct utility in industrial chemical manufacturing or
can be distilled in high yields to all classes of combustible fuels, including gasoline
(67%), aviation fuels (15%) and diesel (15%) (carbon chain-length, distillation
temperature, % volume conversion) (12) (A). The biosynthetic origin of the B. braunii
triterpene oils has remained enigmatic. Poulter (13) suggested that the biosynthesis of
the botryococcene scaffold could arise from a mechanism similar to that for squalene, a
key intermediate in sterol and cyclized triterpene metabolism (B). Squalene biosynthesis
13

occurs from an initial head-to-head condensation of two farnesyl diphosphate molecules
(FPP) into the stable intermediate pre-squalene diphosphate (PSPP), followed by a
reductive rearrangement to form squalene catalyzed by a single enzyme without release
of the PSPP intermediate (40). Botryococcene biosynthesis is suggested to parallel that
of squalene in the first half-reaction, differing only in the reductive rearrangement of
PSPP to yield the methyl/ethyl branched, 1’-3 linked botryococcene product.
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proceeding through PSPP, followed by a reductive rearrangement yielding a C3-C1’
linkage between the two farnesyl precursors and possessing an ethyl as well as a methyl
group at C3 in the final product.
Extensive investigations of squalene synthase including site-direct mutagenesis (34) and
structural elucidation of 3-dimensional structure (35) have focused on five highly
conserved domains (domains I-V) thought associated with catalysis (36). Many studies
have also utilized these highly conserved domains as a means for isolating the
corresponding genes from a diverse range of organisms. For instance, the Cappell
laboratory previously described the functional characterization of a squalene synthase
gene from B. braunii race B (37). In that work, degenerate oligonucleotide primers
complementary to several of the conserved domains were used to amplify a small region
of a putative squalene synthase gene, and that gene fragment was then used to isolate
a full-length cDNA from a cDNA library. Heterologous expression of that cDNA in
bacteria and in vitro characterization of the encoded enzyme validated that the cDNA
encoded for a squalene synthase enzyme, but lacked any detectable botryococcene
synthase activity.
The current results represent efforts to define the botryococcene biosynthetic pathway,
to capture the genes coding for these unique enzymological transformations, and to
reconstruct the initial steps of these unusual triterpene pathways in a heterologous host.
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Results

Functional Identification of Genes for Triterpene Biosynthesis
Because we surmised that a botryococcene synthase enzyme might possess amino acid
domains in common with squalene synthase, the B. braunii squalene synthase cDNA
was used to re-screen the B. braunii cDNA library under low stringency hybridization
conditions. A unique squalene synthase-like gene (SSL-1) was isolated and
characterized. The SSL-1 gene predicted a squalene synthase-like protein exhibiting
some resemblance to other squalene synthase enzymes within domains I-V, but missing
a carboxy-terminal, membrane-spanning domain (Figure 2.2). Surprisingly, purified
bacterial expressed SSL-1 protein did not exhibit either squalene nor botryococcene
biosynthesis when assayed in vitro even in the presence of a variety of reducing cofactors like NADPH (Figure 2.3a and 2.4), ferredoxin or cytochrome B5 systems.
However, when SSL-1 was expressed in a yeast engineered for high-level production of
FPP and having its endogenous squalene synthase and squalene epoxidase genes
inactivated, pre-squalene alcohol (PSOH), the dephosphorylated form of PSPP,
accumulated to significant levels (Figure 2.5B). Subsequent incubations of SSL-1 with
radiolabeled FPP confirmed robust in vitro production of PSPP as the sole reaction
product with a Km for FPP of 12.8 µM and catalytic turnover rate (kcat) equal to 2.7 x 102
/sec with no stimulation of activity by NADPH addition (Figs. 2.4 and 2.5J). This
suggested that SSL-1 was catalytically competent for the first half-reaction of squalene
synthase, but perhaps required additional conditions or algal factors for complete
catalytic activity. Mixing the purified SSL-1 enzyme with algal cell-free lysate did indeed
enhance NAD(P)H-dependent botryococcene biosynthesis up to 10-fold, which was also
proportional to the amount of the purified SSL-1 protein or the algal lysate added (Figure
2.3A-C). The mechanism for botryococcene biosynthesis thus appeared to be similar to
squalene synthase in its first half-reaction, catalysis of PSPP formation, but differed in
requiring another algal co-factor that either shuttled reducing equivalents to the reaction
mechanism of SSL-1 or participated directly in the conversion of PSPP to
botryococcene.
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Figure 2.2 Amino acid alignment of SSL enzymes.
Amino acid alignment of BSS, SSL-1, SSL-2, and SSL-3 from B. braunii race B. Five
highly conserved domains among squalene synthase’s identified by Robinson et al. (36),
and the “FLAP” and putative NADPH-binding site identified by Gu et al. (34) are boxed
and labeled in blue. Amino acids completely conserved in the squalene synthase of B.
braunii (AF205791), C. reinhardtii (XM_001703395), A. thaliana (NM_119630), N.
tabacum (U60057), H. sapiens (NM_004462), R. norvegicus (NM_019238), S.
cerevisiae (X59959), S. pombe (NM_001021271), and Y. lipolytica (AF092497) are
17

labeled above the alignment in green, and those residues also conserved with these
squalene synthases and dehydrosqualene synthase (CrtM) from S. aureus (AM920687)
are labeled in red. Residues of CrtM identified by Lin et al. (52) as important for the first
and second half-reactions are labeled with a star. Possible membrane-spanning regions
of BSS and SSL2 as predicted by TMpred are underlined. In the subsequent studies, a
carboxy terminal truncated form of SSL2 (tr2) missing the putative membrane-spanning
domain after D392 (indicated by arrow) was heterologously expressed in bacteria.
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Figure 2.3 Dependence of the SSL-1 enzyme on algal lysate for botryococcene
biosynthesis.
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Purified SSL-1 enzyme (1 µg) (SSL-1), B. braunii 2000g whole-cell lysate (10 µg protein)
(Lys), and equal aliquots of both SSL-1 and lysate were incubated with radiolabeled
FPP, with (+) or without (-) 2mM NADPH and the incorporation into squalene and
botryococcene determined by TLC separation of the reaction products followed by
scintillation counting of the corresponding zones (panel a). Increasing amounts of
purified SSL-1 were incubated with 10 µg of B. braunii 2000g whole-cell lysate and the
incorporation of radiolabeled FPP into squalene and botryococcene determined by TLC
separation/scintillation counting (panel b). B. braunii 2000g whole-cell lysates were
prepared from cells collected at the indicated times (weeks) after subculturing, and
aliquots containing 10 µg of protein were incubated without (-) or with (+) 1 µg of purified
SSL-1 protein, and incorporation of radiolabeled FPP into squalene and botryococcene
determined. The SSL-1 gene containing a 5’ terminal sequence coding for a hexahistidine tag was over-expressed in E. coli, and the corresponding enzyme purified by
nickel affinity chromatography according to the manufacturer (Novagen). B. braunii
lysate was prepared from cells collected at the indicated stages of culture development
according to the procedure described by Okada et al., (2004), and 10 µg of lysate
protein was per assay. Assays were incubated at 37°C for 1h, then the reaction products
extracted with hexane. Aliquots of the hexane extracts was separated by silica TLC and
the radioactivity migrating to zones corresponding to authentic standards of
botryococcene and squalene determined by scintillation counting.
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Figure 2.4 Michaelis-Menten enzyme kinetics of SSL-1.
Enzyme assays (50 µl) were set up as described in the methods section with purified
SSL-1 (0.2 – 1.0 µg) and the indicated concentration of 3H-FPP. Assays also contained
0.1% Triton X-100 and ± NADPH. Assays were incubated for 15 min at 37°C and
stopped by addition of 50 µl 0.5 M EDTA. The reactions were then extracted three times
with 200 µl water saturated 1-butanol and pooled in a 4 mL glass screw cap vial. The
butanol was evaporated with a stream of nitrogen gas, and the white residue was
resuspended in 2 mL of acid phosphatase solution ( 20% 1-propanol (v/v), 100 mM
sodium acetate pH 4.7, 0.1% Triton X-100, 10 U sweet potato acid phosphatase) and
incubated 12-16 h in a 28°C shaker. Dephosphorylated products were extracted three
times with 1 mL n-hexane, pooled, dried with a stream of nitrogen gas, and resuspended
in 200 µl of n-hexane. Aliquots of the hexane extract were spotted on reverse-phase
TLC plates along with standards of FOH and PSOH and developed with
methanol:acetone (8:2). The standards were visualized with iodine vapors, and the
zones corresponding to FOH (rf= 0.65) and PSOH (rf= 0.45) were scraped and analyzed
by scintillation spectroscopy. Addition of NADPH had no significant effect on enzyme
activity and greater than 90% of the expected radioactivity was recovered in the FOH
and PSOH zones indicating that PSPP is the dominant reaction product formed from
FPP. The data was analyzed using the SigmaPlot Enzyme Kinetics 1.3 module. Data
represents mean ± S.E.M.
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Figure 2.5
Functional characterization of the squalene synthase-like genes of
Botryococcus braunii race B.
The squalene synthase-like genes, SSL-1, SSL-2 and SSL-3, were expressed in yeast
separately (SSL-1(B), SSL-2(C) or SSL-3(D)) or in combinations (SSL-1 + SSL-2(E),
SSL-1 + SSL-3(F)) and the hexane extractable metabolites profiled by GC-MS. The
chemical profile of yeast not engineered with any gene constructs serves as the
background control (A). The SSL genes were also expressed in bacteria, the affinitytagged proteins purified and assayed separately (SSL-2 (G)) or in combinations (SSL-1
+ SSL-2 (H); SSL-1 + SSL-3 (I)) for the reaction products generated upon incubation
with FPP and profiled by GC-MS (G-I), or for quantitative determination of radiolabeled
FPP incorporated into specific reaction products separated by TLC (J). Data (J)
represents mean ± S.E.M. obtained from three independent experiments (n=3). The
chromatograms (A-I) are also annotated for the elution behavior of botryococcene (1),
squalene (2), presqualene alcohol (3) and bisfarnesyl ether (4).
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Because no natural occurring squalene synthase catalyzing only the first or second halfreactions has been reported, we reasoned that other squalene synthase-like cDNAs for
botryococcene biosynthesis might exist. We undertook an exhaustive assessment of the
SSL genes expressed in the Botryococcus braunii race B cells. The transcriptomic data
from two independent sequencing efforts were assembled and screened computationally
for additional squalene synthase-like genes. Two additional SSL genes were uncovered
and labeled SSL-2 and SSL-3 (Figure 2.2). Although both of the predicted proteins
showed amino acid sequence similarity to other squalene synthases in excess of 62%,
neither bacterial-expressed, purified enzymes exhibited any botryococcene biosynthesis
and only SSL-2 showed a low capacity for squalene biosynthesis when incubated with
FPP as substrate (Figure 2.5G). When expressed in yeast, SSL-3 also did not cause the
accumulation of any distinct products (Figure 2.5D), but SSL-2 resulted in the
accumulation of a small amount of squalene (~10% of the total) and a terpene of
unknown structure (Figure 2.5C). The dominant terpene accumulating in the SSL-2
expressing yeast was subsequently identified by NMR as bisfarnesyl ether and
confirmed by comparative analysis of corresponding ether prepared by chemical
synthesis (Figure 2.6). Subsequent analysis of the reaction products generated by in
vitro incubation of SSL-2 with FPP also verified this enzyme as the source of this unique
terpene (Figure 2.5G & J).
The observations of unique terpene products from squalene synthase-like enzymes in
Botryococcus, namely PSPP by SSL-1 and bisfarnesyl ether by SSL-2, suggested that
triterpene metabolism in this alga operates differently from that in other organisms. We
considered the possibility that multiple SSL proteins might be required in botryococcene
biosynthesis. To evaluate this possibility, the different SSL genes were co-expressed in
yeast, or the heterologous expressed and purified proteins were incubated in various
combinations. When SSL-1 was co-expressed with SSL-2, the amount of squalene
accumulating increased about 30-fold (Figure 2.5E) along with a significant accumulation
of bisfarnesyl ether. When purified SSL-1 and SSL-2 enzymes were incubated in a 1:1
stoichiometric ratio, squalene accumulation predominated (Figure 2.5H), suggesting that
something different mechanistically might be occurring when the SSL-1 and 2 genes
were co-expressed in yeast (see below). Most surprising, when SSL-1 and SSL-3 were
co-expressed, botryococcene accumulation became readily apparent and accumulated
to levels of 20 mg/L along with 0.7 mg/L of squalene (Figure 2.5F). In vitro incubations of
the purified SSL-1 and SSL-3 proteins confirmed botryococcene as the predominant
reaction product with squalene representing only 3-4% of the total reaction products
(Figure 2.5I & J). Additional in vitro studies have also confirmed that both SSL-2 and
SSL-3 are able to efficiently catalyze the biosynthesis of squalene and botryococcene,
respectively, from PSPP but not FPP, and these activities of SSL-2 and SSL-3 are
sufficient to account for all the squalene and botryococcene biosynthesized in combined
assays with SSL-1 (Figure 2.7).
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Figure 2.6 GC chromatographs of unknown triterpene purified from yeast overexpressing the SSL-2 gene (a) in comparison to chemically synthesized bisfarnesyl
ether (b).
The MS for the dominant peak compounds with retention time of 8.38 min in panels a
and b are shown in panels c and d, respectively. Chemically synthesized bisfarnesyl
ether produced an identical NMR spectrum to the unknown triterpene purified from yeast
over-expressing the SSL-2 gene.
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Figure 2.7 Enzyme assays showing PSPP utilization by SSL-2 and SSL-3.
Two primary enzyme assays (500 μL) were set up with 20 μg of purified SSL-1 or
Nicotiana benthamiana squalene synthase (TSS) and containing 20 μM 3H-FPP. The
assays were incubated at 37˚C for 1 h, then extracted three times with 500 μL water
saturated 1-butanol, pooled, and evaporated under a stream of nitrogen gas. The white
residue was resuspended in 50 μL of 25 mM NH4HCO3 in 70% ethanol (v/v). An aliquot
of the resuspension was analyzed by the acid phosphatase assay (described in Figure
2.4) and shown to consist of 45% and 40% PSPP for the SSL-1 and TSS primary
incubations, respectively (the remaining 55% and 60% consisting of FPP). It was
calculated that 1 μL of each resuspension contained ~150 pmoles of 3H-PSPP.
Secondary enzyme assays (50 μL) were set up containing 1 μL of resuspension (3 μM
PSPP), 2 mM NADPH, and 1 μg of SSL-2 or SSL-3. For comparison, enzyme assays
were set up containing 3 μM FPP, 2 mM NADPH and either 1 μg each of SSL-1 and
SSL-2 or SSL-1 and SSL-3, and 5 μM FPP, 2 mM NADPH, and 1 μg of SSL-2 or SSL-3.
Assays were incubated at 37˚C for 15 min, stopped by addition of 50 μL 0.5 M EDTA,
and extracted with 100 μL n-hexane. Aliquots of the hexane extract were spotted on
silica TLC plates with standards of squalene and botryococcene and developed with nhexane. Standards were visualized with iodine vapors and the corresponding zones
were scraped and analyzed by scintillation spectroscopy. The rate of botryococcene
synthesis by SSL-3 or SSL-1 + SSL-3 is shown in blue and squalene synthesis by SSL-2
or SSL-1 + SSL-2 is shown in red. Data represents mean ± S.E.M.
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Mechanistic Considerations for Bisfarnesyl Ether Biosynthesis
When incubated by itself, SSL-2 catalyzes the NADPH-dependent biosynthesis of
approximately ~90% of all-trans bisfarnesyl ether and 10% of squalene (Figure 2.5G).
This suggests that SSL-2 does have the ability to generate PSPP, but at a lower
efficiency relative to ether formation. Based on a consideration of the detailed
carbocation mechanism elucidated for the biosynthesis of squalene from FPP (Figure
2.1B) (13), one might not expect bisfarnesyl ether biosynthesis to involve a PSPP
intermediate. Instead, if the initial carbocation generated on one of the two SSL-2 bound
FPP molecules were quenched by reaction with an available water molecule, and if the
farnesol (FOH) were positioned in the correct orientation and proximity to a second FPP
molecule, displacement of the pyrophosphate group via a SN2 Williamson ether
synthesis-type reaction (38) could yield the bisfarnesyl ether (Figure 2.8). Support for
such a mechanism comes from the incorporation of radiolabeled FOH directly into the
bisfarnesyl ether product, but only when SSL-2 is incubated with both FOH and FPP
(Table 2.1).
To determine if the mechanism of NADPH dependence for bisfarnesyl ether formation by
SSL-2 was catalytic or structural, the quantitative yield of reaction product and NADPH
oxidation were determined. While the biosynthesis of 1072 pmoles of squalene was
correlated with an equal stoichiometric oxidation of 1098 pmoles of NADPH by the
Nicotiana benthamiana squalene synthase enzyme, greater than 21 pmoles of
bisfarnesyl ether were formed by SSL-2 when only 4.6 pmoles of NADPH were oxidized
(Table 2.2). Approximately half of the NADPH oxidation by SSL-2 under these conditions
is associated with the biosynthesis of 2.2 pmoles of squalene (Table 2.2). About 10
times more bisfarnesyl ether is formed per mole equivalent of NADPH oxidation (21
pmoles versus 2.4 pmoles), consistent with an allosteric or structural role for NADPH in
the SSL-2 bisfarnesyl ether reaction rather than a catalytic one. A similar role for
NADPH in stimulating PSPP formation by squalene synthases was reported earlier (33,
39, 40).
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Figure 2.8 Proposed mechanism for bisfarnesyl ether biosynthesis by SSL-2.
When two molecules of FPP are bound by the SSL-2 enzyme, dissociation of the
diphosphate substituent from one creates a carbocation, which can react with a water
molecule in close proximity to generate farnesol (FOH). If the FOH is appropriately
positioned relative to the second FPP molecule, a reaction akin to a Williamson ether
synthesis (38) reaction could occur to yield bisfarnesyl ether.
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Table 2.1 Substrate specificity of SSL-2

Substrate

Bisfarnesyl ether formed
(pmoles /h•µg protein)

3

0

FPP + 3H-farnesol

16.3 +/- 0.4

3

13.5 +/- 3.3

H-farnesol

H-FPP

Purified SSL-2 protein (2 µg) was incubated with either 10 µM 1-3H-farnesol, 10 µM 13
H-farnesol and 10 µM FPP, or 10 µM 1-3H-FPP in a 50 µL reaction at 37oC for 1 h, the
reaction products extracted with MTBE, and aliquots separated on silica TLC plates. The
radioactivity incorporated in the zones corresponding to bisfarnesyl ether were
determined by scintillation counting. Data represents mean ± S.E.M.
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Table 2.2 NADPH oxidation by SSL-2

Assays were performed as described above in the Methods except that an alternative
reaction buffer (50 mM Tris pH 8.0, 250 mM NaCl, 20 mM MgCl2) was used to minimize
spontaneous NADPH oxidation and prevent protein precipitation at high concentrations.
All the assays also contained 100 μM NADPH and 40 μM FPP in 300 μL final reaction
volumes. The oxidation of NADPH was monitored at 340 nm with a Biorad SmartSpec
Plus at room temperature (23°C). An extinction coefficient of 6220/M/cm was used to
calculate the amount of NADPH oxidized. No NADPH oxidation could be measured in
complete reaction buffer without protein over a 1 h incubation. When either N.
benthamiana squalene synthase (TSS) or SSL-2 was incubated in reaction buffer
without FPP, NADPH was oxidized at a rate of 24 and 22 pmoles/μg protein/h,
respectively, suggesting that both enzymes cause a slight oxidation of NADPH that is
uncoupled with squalene or bisfarnesyl ether biosynthesis. This background NADPH
oxidation was subtracted from the experimentally determined rates. The experimental
enzyme assays contained either purified TSS (0.75 or 1.5 μg) or SSL-2 (8 or 16 μg) and
40 μM 3H-FPP. Absorbance at 430 nm was recorded every 2.5 min. for 15 minutes, after
which the reaction was stopped by adding an equal volume of 0.5 M EDTA. The reaction
mixture was collected, extracted with 200 μL of hexane and aliquots were separated by
silica TLC along with standards of squalene and bisfarnesyl ether using hexane:MTBE
(25:1) as the developing solvent. The standards were subsequently visualized with
iodine vapor, and corresponding zones were analyzed by scintillation spectroscopy.
Data represents mean ± S.E.M of duplicate samples.
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Improving the Efficiency of Botryococcene Biosynthesis
Production of botryococcene by yeast was improved by engineering different
configurations of the SSL-1 and 3 genes (Figure 2.9). While co-expression of SSL-1 and
SSL-3 yielded significant botryococcene, peptide fusions of SSL-1 and SSL-3 connected
by a triplet repeat linker of GGSG improved production capacity greater than two-fold to
upwards of 50 mg/L. Further enhancement to over 70 mg/L was observed by appending
the carboxy-terminal 63 or 71 amino acids of the Botryococcus squalene synthase on to
the carboxy-termini of SSL-1 and SSL-3 enzymes, respectively. These terminal amino
acids serve to tether squalene synthase, and by inference SSL-1 and 3, to the yeast’s
endo-membrane system, which presumably brings the enzymes in closer proximity to
one another or give the enzymes greater access to endogenous FPP pools. Further
support for this notion has been the observation of greater than 100 mg/L of
botryococcene by yeast over-expressing gene fusions of SSL-1 and SSL-3 harboring the
putative ER membrane targeting sequence of the botryococcus squalene synthase.
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Figure 2.9 Comparison of botryococcene production in yeast engineered with different
configurations of SSL-1 and SSL-3.
Yeast line TN7 was engineered with the SSL-1 and SSL-3 genes on separate plasmids
(squares), with gene fusions (SSL-1 fused to SSL-3 via a triplet repeat of GGSG
(triangles), or vice versa (diamonds)), or with 63 or 71 amino acids of the carboxy
terminus of the Botryococcus squalene synthase, sequences containing a membranespanning domain, appended to the carboxy termini of the SSL-1 and SSL-3 enzymes,
respectively (circles). The data represents mean ± S.E.M.
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Discussion
The results were unexpected because squalene biosynthesis is known as a two-step
process catalyzed by a single enzyme (Figure 2.10). FPP is first converted to the
intermediate PSPP, followed by its reductive rearrangement to squalene (14). PSPP is
not evident in these reactions unless NADPH, the reducing agent, is omitted from the
incubations (17). Under conditions of adequate NADPH, it is unlikely that PSPP is
released from the squalene synthase enzyme, then re-bound and reduced to squalene
(40). Regardless, a single enzyme is responsible for the entire conversion process, and
this mechanism appears highly conserved from yeast to man, including algae like
Botryococcus (37). In contrast, botryococcene biosynthesis requires the successive
action of two distinct enzymes. First, SSL-1 catalyzes the biosynthesis of PSPP as a
separate and distinct product, which the second enzyme, SSL-3, efficiently converts to
botryococcene in a NADPH-dependent manner. Whatever the evolutionary forces
driving this division of labor might have been, it appears to have occurred twice within
the life history of Botryococcus. When SSL-1 is co-expressed with SSL-2, squalene
accumulates, which we speculate might represent a distinct pool of squalene in
Botryococcus destined to specialized roles like the biogenesis of the extracellular matrix
and other squalene derivatives.
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Figure 2.10 A cartoon depiction of the catalytic roles of the squalene synthase-like
enzymes in Botryococcus braunii race B and their putative contributions to the triterpene
constituents that accumulate.
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The previously identified squalene synthase gene (BSS) (37) is thought to provide
squalene essential for sterol metabolism, whereas the squalene synthase-like genes
SSL-1, SSL-2, and SSL-3 provide the triterpene oils serving specialized functions for the
algae. In combination with SSL-1, SSL-2 could provide squalene for extracellular matrix
and methylated squalene derivatives, while SSL-1 plus SSL-3 generates botryococcene,
which along with its methyl derivatives, accounts for the majority of the triterpene oil.
Support for the neofunctionalization of these unusual binary systems for triterpene
biosynthesis is provided by the distinctive biosynthetic activities associated with SSL-2
(Figure 2.10). First, this enzyme catalyzes the NADPH-dependent biosynthesis of an
unusual terpene ether. There are no reports of bisfarnesyl ether accumulation in
Botryococcus or any other organism, but it could be incorporated into other more
complex matrix polymers which would have masked its detection. One possible means
for bisfarnesyl ether biosynthesis does not involve a PSPP intermediate, but instead an
alternative reactivity of two bound farnesyl moieties via a SN2 Williamson ether
synthesis-type reaction (Figure 2.3) (38). Support for such a mechanism comes from the
incorporation of radiolabeled FOH directly into the bisfarnesyl ether product, but only
when SSL-2 is incubated with both FOH and FPP (Table 2.1). Second, the accumulation
of both squalene and bisfarnesyl ether in yeast co-expressing SSL-1 and SSL-2 is also
consistent with this proposed mechanism. The yeast line used for these studies is
engineered for high FPP production, but tends to accumulate FOH as a consequence of
FPP dephosphorylation catalyzed by endogenous phosphatases (41, 22). Hence, the
yeast co-expressing SSL-1 and SSL-2 has significant pools of FOH and FPP, which will
compete with any PSPP generated by SSL-1 for binding and catalysis by SSL-2. Third,
while there is no obvious or direct chemical requirement for reducing equivalents in the
biosynthesis of the bisfarnesyl ether from FPP and FOH, the significance of the NADPH
dependence might relate to a structural role rather than a catalytic one. Pandit et al. (35)
suggested that NADPH binding to its putative bind site in the human squalene synthase
might stabilize a region of the enzyme not well resolved in the crystal structure, and thus
positioning a domain into close association with the active site. NADPH binding to the
SSL-2 enzyme could evoke a similar conformational change that renders the SSL-2
enzyme competent for either bisfarnesyl ether or squalene biosynthesis dependent on
available substrates (FPP, FOH and PSPP). Hence, not only has SSL-2 maintained its
catalytic ability to convert PSPP to squalene, it has evolved a novel catalytic activity
yielding a bisprenyl ether from prenyl diphosphates.
One possibility for how these unique triterpene synthases arose is that a progenitor
squalene synthase gene could have duplicated to yield multiple gene copies. While one
copy (BSS) maintained its coding capacity for squalene synthase activity, essential for
sterol metabolism, the other copies (SSL-1, SSL-2, and SSL-3) would have afforded
opportunities for evolutionary diversification. Alternatively, Botryococcus could have
acquired multiple copies of SSL genes by a horizontal gene transfer process, and those
genes may have evolved specialized synthase-like activities. For example, one of the
acquired squalene synthase like genes could have evolved the capacity for
botryococcene biosynthesis and a subsequent gene duplication event could have
resulted in loss of function for either the first half-reaction or the second (45). No matter
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the specific mechanism, what makes the possible events associated with the
neofunctionalization of the SSL enzymes particularly intriguing is that specialized
triterpene oil accumulation, like botryococcene, could not have occurred without both
SSL-1 and SSL-3 evolving in concert with one another.
There are other examples of similar division and diversification of enzymological
capacities within key genes for pyrimidine (42), diterpene (43), and triterpene (44)
metabolism. For instance, biosynthesis of the diterpene, kaurene, in many fungi relies on
a single, multifunctional enzyme (45) that catalyzes the conversion of the linear
isoprenoid intermediate, geranylgeranyl diphosphate, to the bicyclic copalyl diphosphate
(CPP) product. CPP then undergoes a second cyclization reaction initiated at a separate
binding site on the same enzyme to yield kaurene. In higher plants, the enzymes for
CPP and kaurene biosynthesis are encoded by separate and distinct genes (43).
Specific CPP synthases within rice catalyze the biosynthesis of either ent-CPP or synCPP isomers (46, 47). These are complemented with equally distinct diterpene
synthases that can utilize one or the other CPP isomer for hormone or defense
compound biosynthesis (48, 49). Yet, there are other diterpene synthases that have
retained these two enzyme functions, but have evolved whole new catalytic outcomes
(50). Osbourn and co-workers (44, 51) have provided evidence that the genes encoding
for the enzymes catalyzing the cyclization of oxidosqualene to distinct tetra- and pentacyclic classes of triterpenes, primarily sterols and defense related saponins, respectively,
likely arose from common ancestor genes evolving novel catalytic functions dedicated to
primary and specialized metabolism. Microbial forms of dihydrosqualene synthase, like
CrtM, might also be considered an example of squalene synthase-like enzyme
diversification (52, 53). CrtM relies on PSPP biosynthesis, but does not utilize NADPH
for the second half-reaction. CrtM instead yields dehydrosqualene, a reaction product
with much in common with phytoene, the tetraterpene equivalent of dehydrosqualene,
and by inference shares catalytic features of the second half-reaction in common with
phytoene synthase. Nonetheless, what distinguishes the current results from all the
others is there are no other known examples where the half-reaction specificity of
squalene synthases appear separated from one another and subject to evolutionary
diversification, except for that reported here for Botryococcus.
The family of squalene synthase-like enzymes in Botryococcus is also informative
relative to the recent elucidation of the crystal structure of dehydrosqualene synthase
(CrtM) of Staphylococcus aureus, a target enzyme for a new generation of anti-infective
reagents, along with refinements in the human squalene synthase structure (52, 53).
Those studies detailed how two FPP molecules bind to CrtM and human squalene
synthase, are converted to the PSPP intermediate, and then re-positioned in the active
site pocket in preparation for the second half-reaction. Key residues identified include
those that coordinate magnesium ions for their interactions with the diphosphate
substituents of the FPPs and PSPP, which are involved in both half-reactions. Based on
sequence alignments (Figure 2.2), many of these residues (S19, Y41, R45, D48, D52,
Y129, N168, and D177, numbering according to CrtM and annotated by a star above the
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residue in Figure 2.2) appear conserved in the Botryococcus squalene synthase and all
three of the SSL enzymes. Because SSL-2 and SSL-3 are deficient in PSPP
biosynthesis, these particular residues are not by themselves sufficient for PSPP
biosynthesis. Conversely, since SSL-1 can only catalyze the formation of PSPP, these
same residues do not appear sufficient to initiate the second half-reaction. Amino acids
at other positions are undoubtedly important for PSPP formation and the catalytic
specificity of the second half-reaction, squalene versus botryococcene biosynthesis.
Experiments to functionally define which amino acids at which positions are responsible
for the enzymological specificity of these triterpene synthases will be significantly
advantaged by having these unique Botryococcus SSL enzymes which are specialized
to either the first half-reaction or the second.
Altogether, our results establish that botryococcene and squalene oils are synthesized in
Botryococcus braunii race B by the combined action of separate and distinct squalene
synthase-like enzymes. These findings have opened up new avenues for understanding
the chemical specificity and diversification within this class of enzymes and provide a
demonstration for the bioengineering and production of a potentially valuable
petrochemical replacement.
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Methods
Reagents
[1-3H]Trans, trans farnesol, and [1-3H]FPP were purchased from ARC (St. Louis, MO).
All other reagents were purchased from Sigma (St. Louis, MO) unless stated otherwise.

Culturing of B. braunii
Botryococcus braunii Berkeley (Showa) strain was grown as previously described (16),
except that cultures were aerated with filter sterilized air containing 2.5% CO 2. Algal
cells were collected by vacuum filtration using a 20 µM nylon mesh, then scrapped into
collection tubes, snap frozen in liquid N2 and stored at -80ºC until further use.

Cloning SSL-1
Plaque lifts of a B. braunii cDNA library previously described by Okada et al. (37) were
prepared and hybridized with the full-length B. braunii squalene synthase cDNA
radiolabeled with [α-32P]dCTP using a Prime-It kit (Stratagene). Hybridization was
performed at 30°C in hybridization buffer consisting of 5X SSPE, 2X Denhardt’s solution,
0.2% SDS, 100 μg mL - 1 salmon sperm DNA and 40% formamide (34). The plaque lifts
were washed three times at room temperature for 5 min with 2X SSC, 0.1% SDS and
hybridization detected by autoradiography. After 2 rounds of plaque purification, isolated
plaques were converted to their plasmid forms according to the manufacturer’s
instructions (Stratagene), restriction digestions of the isolated plasmids compared, and
only those showing distinctive differences to that for the Botryococcus squalene
synthase examined further by automated DNA sequencing. DNA sequence of the
squalene synthase-like (SSL-1) cDNA clone yielded a putative full-length open reading
frame (ORF) coding for a 402 amino acid protein having a predicted molecular size of
45,692 daltons.
SSL-1 was cloned into the pET28a vector via the cloning site BamHI/XhoI in order to
generate a SSL-1 protein with an amino terminal hexa-histidine extension to aid in
purification. The SSL-1 gene was also inserted into two standard yeast expression
vectors, YEp352 harboring an ADH1 promoter and Ura3 selection via the cloning site
EcoRI/HindIII, and pESC harboring an AHD1 promoter and Leu2 selection via the
cloning site BamHI/NotI (22).
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Cloning SSL-2
Transcriptomic sequencing was performed using RNA pooled from B. braunii cultures
ranging from 1-4 weeks after subculturing. cDNA samples were prepared for de novo
transcriptome sequencing, and the resulting cDNA samples processed for DNA
sequencing according to the emPCR Method Manual (Roche). Sequencing was
performed on a Roche Genome Sequencer FLX and the data assembled using Newbler
(Roche). The assembled DNA sequence data was computationally screened using the
NCBI blast search function with the Botryococcus squalene synthase cDNA sequence
as the query, which revealed a partial ORF with strong similarity to the amino terminal
halves of BSS and SSL-1. To determine the full length sequence for this SS - like gene
(termed SSL-2), an aliquot of plasmid DNA derived from the phage cDNA library
described above (using the mass excision protocol as described by Stratagene) was
used in PCR reactions with primers specific to SSL-2 and primers specific to the
pBluescript SK- vector in attempt to amplify the missing 3’ sequence of SSL-2. An 800
bp band was isolated, ligated into the pGEM T-Easy vector (Promega), and sequenced.
This sequence information was used to deduce the full length sequence for SSL-2,
which encodes for a predicted protein consisting of 465 amino acids and having a
molecular size of 52,149 daltons.
The full length SSL-2 cDNA was cloned into the Yep352 yeast expression vector via the
cloning site EcoRI/NotI. Because SSL-2 encodes for a protein with at least one
predicted membrane-spanning region at its C-terminus, we designed a truncated form of
SSL-2 in which 73 C-terminal amino acids were deleted (SSL-2-tr2). SSL-2-tr2 was
cloned into the pET28a vector via the cloning site EcoRI/NotI.

Cloning SSL-3
The DNA sequence data obtained from a second transcriptomic profiling effort
(www.jgi.doe.gov/sequencing/why/bbraunii.html) was combined with the first, and the
combined dataset assembled with CLC Genomics Workbench (CLC Bio). Screening of
this dataset with the Botryococcus squalene synthase revealed another ORF encoding a
383 amino acid squalene synthase-like (SSL-3) protein with a predicted molecular size
of 44,127 daltons. SSL-3 was cloned into the pET28a and Yep352 vectors via the
cloning sites EcoRI/NotI.
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Protein Expression, Purification, and Enzyme Assays
The recombinant vectors were transformed into E. coli strain BL21(DE3) according to
the manufacturer’s recommendations (Novagen). The selected lines were grown with
kanamycin selection at 37ºC with vigorous shaking until the cultures reached an optical
density of ~0.8 (OD600 nm), then expression of the corresponding SSL gene induced by
addition of 0.5 mM isopropylthio- -D-galactoside (IPTG) and the cultures incubate for an
additional 3 to 20 h with shaking at room temperature. One hundred mL of the culture
was subject to centrifugation at 4,000 g for 10 min, the pelleted cells resuspended in 10
mL of lysis buffer containing 50 mM NaH2PO4, pH 7.8, 300 mM NaCl, 10 mM imidazole,
1 mM MgCl2, 1 mM PMSF, 1% glycerol (v/v), then sonicated 4 x for 10 sec with a
microprobe sonicator at 60% maximum power. The samples were cooled on ice for 2
min between sonication treatments. The sonicate was centrifuged at 16,000 g for 10 min
at 4°C and the supernatant used for purification of the hexa-histidine tagged enzymes.
Purification of the bacterial expressed enzymes was afforded by the amino-terminal
hexa-histidine tag using His-Select Cobalt affinity gel (Sigma) columns according the
manufacturer’s recommendations. Recovery of proteins with the expected molecular
sizes was determined by SDS-PAGE. The purified protein fractions were concentrated
using Amicon Ultra (0.5 ml, 10K) centrifugation filter units and stored in 300 mM NaCl,
20 mM Tris-HCl pH 7.5, 5 mM dithiothreitol, 2 mM MgCL2, 50% glycerol (v/v) at -20°C for
2-3 weeks without noticeable loss of activity.
Typical enzyme assays were initiated by mixing aliquots of purified enzyme with 50 mM
Mops, pH 7.3, 20 mM MgCl2, 2.5 mM 2-mercaptoethanol, 10 μM [1-3H]-FPP (~2x105
dpm total), and 2 mM NADPH in total reaction volume of 50 μL. Reactions were
incubated at 37ºC for 1 h and then extracted with 100 µl n-hexane or 100 ul MTBE.
Forty μL of the n-hexane or MTBE extract was then spotted onto silica TLC plates with
authentic standards of botryococcene and squalene and developed with n-hexane, or
standards of bisfarnesyl ether and developed with n-hexane:MTBE, 25:1. The standards
were visualized with iodine vapors and TLC zones corresponding to the standards were
scrapped and analyzed by scintillation spectrometry. If Botryococcus lysate was added
to enzyme assays, typically 5 μL of lysate (corresponding to 10 µg total protein)
prepared from B. braunii cells according to Okada et al. (50) was added. Cold assays
were scaled up to 0.5 mL total volume and contained 10 μM FPP. Assays were
extracted once with 1 mL n-hexane, then with 1 mL MTBE, the organic extracts pooled,
and solvent evaporated under a stream of N2. Extracts were resuspended in 50 μL
hexane and an aliquot analyzed by GC-MS with a Varian CP-3800 GC coupled to a
Varian Saturn 2200 MS/MS (Varian Medical Systems) using a Supelco SLB-5ms fused
silica capillary column (30 m x 0.25 mm x 0.25 μM film thickness, Supelco). Initial oven
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temperature was set at 220°C for 1 min., ramped to 280°C at 20°C/min., then ramped to
298°C at 3°C/min.

Expression in Yeast
A yeast line, CALI-7, developed previously for the generation of high intracellular
concentrations of FPP was used for these purposes (41, 22). One further modification
was an insertional inactivation of the ERG 1 gene. The insertional mutation of this gene
was created by introducing the TRP1 gene flanked by DNA sequences of the 5’ and 3’
region of the ERG 1 gene into the CALI-7 cells and subsequent selection for reversion of
tryptophan auxotrophic growth according to the method of Wang et al. (55). This
modified yeast line capable of accumulating high levels of FPP but not metabolizing
squalene is referred to as TN7.
The various recombinant yeast expression vectors were introduced into the TN7 yeast
line via lithium acetate transformation, followed by selection for uracil and leucine
auoxtrophic growth (22). Yeast lines were confirmed to possess the various expression
vectors by colony PCR. Individual colonies of TN7 and the various TN7-transformants
were subsequently grown in 25 mL of YPDE (nutrient rich) or Yeast Synthetic Drop-out
medium (selection) for the indicated time at 25°C before analyzing the cultures for
production of novel triterpene components. In brief, 1 mL aliquots of the culture were
combined with 1 mL of acetone, vigorously mixed, and incubated at room temperature
for 10 min. One mL of hexane was added and mixed vigorously for 60 sec. The mixture
was then centrifuged briefly at 500 g to separate the phases, and the organic phase
removed and concentrated to dryness under a nitrogen stream. The dried extract was
resuspended in 50-500 μL of n-hexane and a 1 μL aliquot analyzed by GC-MS as
described above.

SSL-1 and SSL-3 Yeast Expression Constructs
Fusion constructs were created by employing an assembly PCR strategy as described
by Sun et al. (56). For creation of the SSL-1-SSL-3-fusion construct, oligonucleotide
primers (5’-ccgGAATTCaaaacaatgactatgcaccaagaccacgg, EcoR1 restriction site in bold,
and
5’-ACCAGAACCACCACCAGAACCACCACCAGAACCACCcttggtgggagttg
gggctgcgc, (GGSG)x3 linker in bold) were used with SSL-1 as the template to amplify
SSL-1 with a 3’-extension, and oligonucleotide primers (5’-GGTGGTTCTGGTGGTGG
TTCTGGTGGTGGTTCTGGTatgaaacttcgggaagtcttgc, (GGSG)x3 linker in bold, and 5’ataagaatGCGGCCGCctaagcacccttagctgaaacc, NotI restriction site in bold) were used
with SSL-3 as the template to amplify SSL-3 with a 5’-extension. The two PCR
amplification products were purified and both used in a subsequent PCR reaction with
the flanking oligonucleotide primers (5’-ccgGAATTCaaaacaatgactatgcaccaagaccacgg,
EcoR1 restriction site in bold, and 5’-ataagaatGCGGCCGCctaagcacccttagctgaaacc, NotI
restriction site in bold). The fused amplification product was purified, digested with
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EcoRI and NotI, and ligated into YEp352 (YEp352-SSL-1-3-fus). The SSL-3-SSL-1fusion construct was created similarly (YEP352-SSL-3-1-fus), except that the
oligonucleotide primers (5’-cggGAATTCaaaacaatgaaacttcgggaagtcttgcagc, EcoRI
restriction site in bold, and 5’-ACCAGAACCACCACCAGAACCACCACCAG
AACCACCagcacccttagctgaaacctttcc, (GGSG)x3 linker in bold) were used with SSL-3 as
the
template
and
oligonucleotide
primers
(5’-GGTGGTTCTGGTGGTG
GTTCTGGTGGTGGTTCTGGTatgactatgcaccaaga ccacgg, (GGSG)x3 linker in bold, and
5’-ataagaatGCGGCCGCttacttggtgggagttggggctg cgc, NotI restriction site in bold) were
used with SSL1 as the template.
The SSL1-BSS63 construct was created using the same assembly PCR methodology
with oligonucleotide primers (5’-cgcGGATCCaaaacaatgactatgcaccaagaccacgg, BamHI
restriction site in bold, and 5’-gcgctaacaacttggtgggagttggggctgcgcagaaagatttc) with SSL1 as the template to amplify SSL-1 with a 3’-extension, and oligonucleotide primers 5’ctcccaccaagttgttagcgctgacgggaggcagcttctacc, and 5’-ataaagaatGCGGCCGCttaggc
gctgagtgtgggtctagg, NotI site in bold) with BSS as the template to amplify the c-terminus
of BSS with a 5’-extension. Following completion of the assembly PCR protocol, the
amplification product was digested with BamHI and NotI and ligated into pESC (pESCSSL-1-BSS63). The SSL-3-BSS71 construct was created in the same manner except that
oligonucleotide primers (5’-cggGAATTCaaaacaatgaaacttcgggaagtcttgcagc, EcoRI
restriction site in bold, and 5’-cgtcaaaggtagcacccttagctgaaacctttccatttgattttg) were used
with SSL-3 as the template and (5’-gctaagggtgctacctttgacgaattgaggagcaggttgttagcg, and
5’-ataaagaatGCGGCCGCttaggcgctgagtgtgggtctagg, NotI site in bold) were used with
BSS as the template. The assembly PCR amplicon was ligated into YEp352 (YEP352SSL3-BSS71).

Purification of Bisfarnesyl Ether
TN7 yeast containing YEp352-SSL2 was grown in 1L YPDE media at 25°C for 8 days,
after which hexane extracts were prepared. The raw yeast extracts were then subject to
HPLC separation on a Waters 2695 HPLC with a Waters 2996 Photodiode Array
detector (Waters Corporation) and a Develosil 60-3, 250 mm x 20 mm column (Nomura
Chemical), run with an isocratic solvent (n-hexane:MTBE, 50:1) at 8 ml/min. Under
these conditions, bisfarnesyl ether eluted at ~16 min. Further purification of the
bisfarnesyl ether was afforded by successive chromatographic runs.
Synthesis
of
(2E,6E)-3,7,11-trimethyl-1-((2E,6E)-3,7,11trimethyldodeca-2,6,10trienyloxy)dodeca-2,6,10-triene or Bisfarnesyl Ether
To 81 mg (2.03 mmole, 2 eq) of 60% sodium hydride (washed with anhydrous hexanes
to remove mineral oil) in 1 mL of anhydrous THF under an argon atmosphere at 0oC,
228 mg (1.02 mmol) of trans,trans-farnesol in 1 mL of anhydrous THF was added. The
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mixture was stirred for 10 min, then 438 mg (1.53 mmol, 1.5 eq) of trans,trans-farnesyl
bromide was added in 0.5 mL of anhydrous THF. The mixture was stirred for 20 h and
allowed to warm to 25oC. The reaction was quenched with 2 mL of 1M HCl, diluted with
EtOAc, washed successively with water and brine and dried over anhydrous MgSO4.
The crude product was chromatographed on silica gel F254 preparative TLC plates
(Merck) in 1:10 EtOAc:hexanes to afford 174 mg (40%) of bisfarnesyl ether that had
NMR and mass spectral data identical to that of material produced in enzymatic
reactions (Figure 2.6).

NMR of Bisfarnesyl Ether
1

H and

13

C NMR spectra were recorded on a JEOL alpha 600 NMR spectrometer at
H

C

77.00 for CDCl3.

H NMR (400 MHz, CDCl3)  1.58 (br s, 6), 1.64-1.66 (m, 18), 1.92-2.14 (m, 16),
3.96 (d, J=6.8Hz, 4), 5.04-5.12 (m, 4), 5.32-5.38 (m, 2);
1

C NMR (100 MHz, CDCl3)  16.2 (CH2C(CH3)=CHCH2), 16.7
(CH2C(CH3)=CHCH2O), 17.9 (Z-CH3 of (CH3)2C=CHCH2), 25.9 (E-CH3 of
(CH3)2C=CHCH2), 26.5 ((CH3)2C=CHCH2), 26.9 (CH2C(CH3)=CHCH2), 39.8
(CH2C(CH3)=CHCH2), 39.9 (CH2C(CH3)=CHCH2O), 66.6 (CH2C(CH3)=CHCH2O),
121.3 (CH2C(CH3)=CHCH2O), 124.1((CH3)2C=CHCH2), 124.5
(CH2C(CH3)=CHCH2), 131.5 ((CH3)2C=CHCH2), 135.4 (CH2C(CH3)=CHCH2),
and 140.2 (CH2C(CH3)=CHCH2O).
13

Copyright © Thomas D Niehaus 2011

42

Chapter 3 Funtional Identification of Triterpene Methyltransferases from Botryococcus
braunii race B

Introduction
Botryococcus braunii race B is a colony-forming, green algae that accumulates
triterpene oils to levels in excess of 30% of its dry weight. The composition of the
triterpene oils is dominated by di-methylated and tetra-methylated forms of
botryococcene and squalene. While unusual mechanisms for the biosynthesis of the
botryococcene and squalene were recently described, the enzyme(s) responsible for
decorating these triterpene scaffolds with methyl substituents were unknown. Assuming
that the triterpene methyltransferases (TMTs) might resemble the SAM-dependent
enzymes described for methylating the side chain of sterols, a transcriptome of B.
braunii was screened computationally and six sterol methyltransferase-like genes were
isolated and functionally characterized. Three of these genes when co-expressed in
yeast with complementary squalene synthase or botryococcene synthase expression
cassettes resulted in the accumulation of mono- and di-methylated forms of both
triterpene scaffolds. Unexpectedly, TMT-1 and TMT-2 exhibited preference for squalene
as the methyl acceptor substrate, while TMT-3 showed a preference for the
botryococcene as its methyl acceptor substrate. These in vivo preferences were
confirmed with in vitro assays utilizing microsomal preparations from yeast overexpressing the respective genes, which encode for membrane associate enzymes.
Structural examination of the in vivo yeast generated mono- and di-methylated products
by NMR identified terminal carbons, C-3 and C-22/C-20, as the atomic acceptor sites for
the methyl additions to squalene and botryococcene, respectively. These sites were
identical to those previously reported for the triterpenes extracted from the algae itself.
The availability of closely related triterpene methyltransferases exhibiting distinct
substrate specificities and successive catalytic activities provides an important tool for
investigating the molecular mechanisms responsible for the specificities embedded
within these unique enzymes.
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Background

Botryococcus braunii is a colony-forming, freshwater green alga that has attracted
considerable interest because it reportedly accumulates hydrocarbon oils from 30 to
86% (10) of its dry weight and because these oils are considered progenitors to oil and
coal shale deposits (1, 2, 3). While all B. braunii are morphologically similar, three
distinct chemotypes of B. braunii have been reported depending on the type of
hydrocarbons each accumulates (24). Race A accumulates fatty acid-derived alkadienes
and alkatrienes (5); race L accumulates the tetraterpene lycopadiene (7); and race B
amasses the linear triterpenes, botryococcene, squalene, and their methylated
derivatives (6). Di- and tetra-methylated botryococcenes are generally the most
abundant oil components accumulating in race B (57).
Lower amounts of
tetramethylated-squalene (25) and other structural derivatives of botryococcene and
squalene ranging from C31 to C37 accumulate to various levels in different race B strains
and in response to variable culture conditions (26). The oils accumulate both in
intracellular oil bodies and in association with an extracellular matrix (8), which in race B
consists mainly of long-chain, cross-linked polyacetals formed in large part from
acetalization of polymethylsqualene diols that account for approximately 10% of the dry
weight (21). Other polymethylsqualene derivatives have been described in race B, such
as diepoxy-tetramethylsqualene (27), botryolins (28), and brauixanthins (20). The linear
triterpenes, botryococcene, squalene, and their methylated derivatives, are hence
common components of B. braunii race B and make up a large proportion of its total
biomass.
A unique mechanism for botryococcene biosynthesis was recently described by Niehaus
et al. (58), in which two squalene synthase-like (SSL) enzymes perform the successive
half-reactions that are normally catalyzed by a single enzyme in the case of squalene
synthase. SSL-1 uses farnesyl diphosphate (FPP) as a substrate to catalyze the
production of pre-squalene diphosphate (PSPP), which a second enzyme, SSL-3,
converts to botryococcene in an NADPH-dependent manner. A third enzyme, SSL-2,
catalyzes the biosynthesis of squalene from PSPP produced by SSL-1 but cannot
efficiently use FPP as a substrate. Overall, it was suggested that the squalene and
botryococcene produced by the SSL enzymes were channeled into the production of the
liquid oils and the biosynthesis of squalene derivatives, such as the extracellular matrix
(58), while the conventional B. braunii squalene synthase (37) synthesized squalene
destined for sterol biosynthesis.
It is not botryococcene and squalene, however, which accumulate to substantial levels in
this alga, but the methylated forms of these tripterpenes. For instance, while the liquid oil
content of B. braunii race B is composed primarily of botryococcenes, generally less
than 1% is in the non-methylated C30 form and the majority is dominated by dimethylated
and tetramethylated forms, depending on the strain or culture conditions (26, 59).
Essentially all the squalene that accumulates is in methylated forms, accumulating in the
oil fraction (less than 5% of the total oil (60)) or incorporated into a variety of other B.
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braunii natural products (20, 21, 27, 28). Because B. braunii race B accumulates 40%
or more of its dry weight as these triterpene components, we estimate that the
methylated triterpenes account for at least 30 to 35% of the total algal biomass dry
weight and contribute directly to the buoyancy that distinguishes these algal colonies.
Unlike many green algae that are flagellated and phototaxic (61), the buoyance
characteristic of Botryococcus provides a means for it to float in its normal aqueous
habitats and have greater access to light for photosynthesis. In addition to these
purported physiological roles, the methylated forms of botryococcene and squalene
enhance their utility as feedstocks for petrochemical processing and chemical
manufacturing. The increased branching evident in the methylated triterpenes improves
their hydrocracking to chemical species of value for the synthesis of industrial polymers
and other commodity based chemicals (23) and yields high quality gasoline, kerosene
and diesel fuels upon distillation (12).
While the unique mechanisms for C30 botryococcene and squalene biosynthesis in
Botryococcus braunii have been elucidated (58), the specific mechanism(s) by which
these triterpenes are methylated was unclear at the start of this work. Small-molecule
methylation has been extensively characterized for many diverse compounds and
typically consists of a methyltransferase (MT) that utilizes the universal methyl-donor, Sadenosyl methionine (SAM), and exhibits variable degrees of selectivity for a wide range
of methyl acceptor molecules (62). MTs are also distinguished as C-, O-, N-, S- or halide
methyltransferases, an indication of the methylation target within the acceptor substrate
(63). While MTs may only share limited overall amino acid sequence similarities,
domains responsible for SAM binding (64) appear to be broadly conserved and
conserved structural folds have served to associate MTs into five distinct Classes (65).
Most of the small molecule MTs fall into Class one but do not appear to cluster
phylogenetically based on their target site (i.e. methylation of carbon versus nitrogen) or
the particular chemical class of the methyl acceptor substrate (66). An indole alkaloid
MT, for instance, shows closer sequence similarity to a tocopherol MT rather than any
other alkaloid specific MTs. Clustering in this instance appears more related to the
evolutionary origins of the MTs and the propensity of MTs to undergo
neofunctionalization.
In the current work, we supposed that the methylation of botryococcene and squalene to
their tetra-methylated forms was catalyzed by a single multi-functional MT or multiple
MTs with each responsible for one particular methylation in the catalytic cascade of each
triterpene. We also assumed that because squalene and botryococcene are chemically
and biochemically related to sterols, the methylated forms of triterpenes in B braunii
possibly arose within the same evolutionary timeframe as sterols and the mechanisms
for sterol biosynthesis. Consequently, we searched for homologs of sterol MTs within a
transcriptome of B. braunii, and we provide here the first functional identification of
several interesting triterpene methyltransferases.
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Results

Identification of triterpene methyltransferase candidate genes

We predicted that a methyltransferase that could act on squalene or botryococcene
might resemble a C-24 sterol methyltransferase (SMT) because these enzymes act on
the linear isoprenoid side chain of sterols. A B. braunii transcriptomic database (58)
was screened computationally for cDNAs showing amino acid sequence similarities to
the A. thaliana and C. reinhardtii SMT-1 enzymes. The BLAST search revealed six
candidate genes that were greater than 42% identical and 59% similar to the C.
reinhardtii SMT-1 (Figure 3.1). For comparison, the A. thaliana genome contains three
predicted SMT genes (67), and the C. reinhardtii genome contains only one SMT gene
(68). These particular genes appear overrepresented in B. braunii compared to other
plant and alga and enhanced the prospects these could be triterpene methyltransferases (TMTs). Amino acid alignments revealed that all six candidate genes share
three conserved SAM binding sites as identified by (69); however, the sterol binding
domain II, which is highly conserved in all known plant SMTs, is also conserved in three
of the candidates (SMT-1,-2, and -3), but not in the other three (TMT-1,-2, and -3)
(Figure 3.1).
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Figure 3.1 Amino acid alignment of the six sterol C-24 methyltransferases-like genes
from B. braunii Race B.
Amino acid alignment of the six sterol C-24 methyltransferases-like genes from B.
braunii Race B along with those of C. reinhardtii (EDP05221) and A. thaliana
(AAG28462). Conserved sterol-binding domains (SMT) and S-adenosyl methioninebinding domains (SAM) as identified by (69) are boxed and labeled in blue or red,
respectively.
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In vivo functional characterization of MT activities

To screen the six candidates for TMT capabilities, we coexpressed the various SMT-like
genes in TN7 yeast engineered with either B. braunii squalene synthase (BSS) or a
construct in which SSL-1 and SSL-3 are fused with a (GSGG)3 amino acid linker and
also contains the 73 C-terminal amino acids of BSS fused to its C-terminus (SSL-1-3m).
TN7 yeast engineered with BSS or SSL-1-3m can accumulate squalene or
botryococcene, respectively, to levels above 100 mg/L (Figure 3.2, Figure 3.3B and C).
When SMT-1, -2, or -3 were coexpressed with either BSS or SSL-1-3m, no distinct
products could be detected in organic extracts by GC-MS analysis; however,
coexpression of TMT-1, -2, or -3 all resulted in the accumulation of several unique
products (Figure 3.3D-I). Analysis of the mass spectra of the unique peaks showed
parent ions of 424 and 438 amu (Figure 3.4), suggesting mono- and di-methyltated
triterpenes, respectively.
When TMT-1 was co-expressed with BSS, 63% of the total squalenes accumulated as
methyl-derivatives with 43% accumulating as dimethyl-squalene (Figure 3.3D and 21A).
However, when coexpressed with SSL-1-3m, only 3% of the total botryococcenes
accumulated as monomethyl-botryococcene and no dimethyl-botryococcene was
detected (Figure 3.3G and 21D). Similarly, when TMT-2 was co-expressed with BSS,
40% of squalenes accumulated as methyl-derivatives with 31% accumulating as
monomethyl-squalene (Figure 3.3E and 21B). Only 2% of total botryococcenes
accumulated as monomethyl-botryococcene when co-expressed with SSL-1-3m (Figure
3.3H and 21E). When TMT-3 was co-expressed with BSS, approximately 18% of the
total accumulating squalene was converted to its methyl-derivatives, with 11% of that
was as monomethyl-squalene (Figure 3.3F and 21C). When TMT-3 was co-expressed
with SSL-1-3m, 33% of the accumulating botryococcene was methylated with greater
than half of that in the dimethyl-botryococcene form (Figure 3.3I and 21F).
While the conversion of botryococcene and squalene to their mono- and di-methyl
derivatives were readily detected, no further methylated products (tri- and tetramethylated) accumulated. We considered the possibility that multiple methyltransferases
might act successively and cooperatively in the formation of C34 triterpenes, with one
methyltransferase catalyzing the C30 to C32 conversion and another using C32 as a
substrate to form a C34 triterpene. To test this possibility, yeast expressing either BSS
or SSL-1-3m with TMT-1, TMT-2 or TMT-3 as well as one of the remaining five other
SMT-like B. braunii genes were evaluated for their triterpene content. No unique
products other than the C31 and C32 triterpenes observed in the yeast lines expressing
only TMT-1, -2 or -3 (Figure 3.3) were detected by GC-MS analysis.
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Figure 3.2 Accumulation of triterpenes in yeast engineered with various triterpene
synthases.
Yeast line TN-7 was engineered with either B. braunii squalene synthase (A) or SSL-13m (B) and accumulation of squalene (squares), or botryococcene (triangles) measured.
Yeast was grown in selection media in shake flasks at 30°C for the indicated time and
organic extracts analyzed by GC-MS. Data represents mean ± S.E.M.
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Figure 3.3 Functional characterization of B. braunii race B TMT genes.
Yeast expressing various combinations of triterpene synthase and TMTs were grown in
shake flask for five days and organic extracts analyzed by GC-MS (chromatograms
shown). TMT genes were co-expressed with BSS (squalene synthase) [TMT-1 (D),
TMT-2 (E), and TMT-3 (F)], or SSL-1-3m (botryococcene synthase) [TMT-1 (G), TMT-2
(H), and TMT-3 (I)]. Yeast expressing only BSS (B) or SSL-1-3m (C) or only harboring
empty expression vectors (A) serve as background controls. The chromatograms are
annotated for the elution behavior of botryococcene (1), C31-botryococcene (2), C32botryococcene (3), squalene (4), C31-squalene (5), and C32-squalene (6).
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Figure 3.4 Mass spectra of methyl-triterpenes.
Mass Spectra of C31 squalene (A) and C32 squalene (B) produced in TN7 yeast
expressing BSS and TMT-1, TMT-2 and TMT-3, C31 botryococcene (C) produced in
TN7 yeast expressing SSL-1-3m and TMT-1, TMT-2 and TMT-3, and C32
botryococcene (D) produced in TN7 yeast expressing SSL-1-3m and TMT-3.
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Figure 3.5 Accumulation of triterpenes in yeast engineered with various triterpene
synthases and triterpene methyltransferases (TMT’s).
Yeast were engineered with B. braunii squalene synthase (BSS) and either TMT-1 (A),
TMT-2 (B), or TMT-3 (C) on separate plasmids and accumulation of squalene (closed
circles), C31 squalene (closed squares), and C32 squalene (closed triangles) measured,
or with the botryococcene SSL-1-3m and either TMT-1 (D), TMT-2 (E), or TMT-3 (F) on
separate plasmids and accumulation of botryococcene (open circles), C31 botryococcene
(open squares), and C32 botryococcene (open triangles) measured. Yeast was grown in
shake flasks at 30°C for the indicated time and organic extracts analyzed by GC-MS.
Data represents mean ± S.E.M.
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In vitro biochemical confirmation

To verify the in vivo results with in vitro determinations, the six SMT-like genes were
expressed in yeast and microsomal preparations used as the source of the enzymes in
assays containing 3H-SAM and either botryococcene or squalene as substrates. TMT-1
and TMT-2 readily catalyzed the transfer of a methyl group from SAM to squalene, but
showed less than 1/100 those levels of activity with botryococcene as the acceptor
(Table 3.1). In contrast, TMT-3 favored botryococcene as the methyl acceptor and
exhibited only very modest activity with squalene. None of the other 3 SMT-like genes
showed any measurable methyltransferase activity with botryococcene or squalene as
substrates. None of the six enzymes was able to methylate C32 botryococcene or C32
squalene, possible intermediates to the tetramethylated forms (see below). Equally
surprising, none of the six B. braunii SMT-like genes methylated cycloartenol,
zymosterol, or lanosterol, which suggested we had yet to find the proper substrate(s) for
these MTs, that we have not been able to provide these hydrophobic substrates in a
form available for catalytic turnover, or that the MTs were not catalytic competent under
these in vitro conditions.
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Table 3.1 Substrate preference of the various B. braunii SMT-like enzymes.
Enzyme activity (pmoles/h/µg)
substrate

empty

TMT-1

TMT-2

TMT-3

SMT1

SMT- SMT2
3

squalene

0

513.7±8.6

862.2±59.9

35.4±3.0

0

0

0

botryococcene

0

3.3±1.3

4.5±1.3

434.9±31.8

0

0

0

C32 squalene
C32
botryococcene

0

0

0

0

0

0

0

0

0

0

0

0

0

0

The various B. braunii SMT-like genes or empty vector control were constitutively
expressed in yeast for 3 days, after which microsomes were prepared according to the
methods of Pompon et al. (77). Enzyme assays contained 50 mM HEPES, pH 7.5,
either 0.01% (TMT-3) or 0.1% (all other samples) DHPC, 2 mM acceptor substrate
(botryococcene, squalene, C32 botryococcene, C32 squalene), 50 µM 3H-SAM (~150
dpm/pmole), 2 µL aliquots of microsomes (~ µg protein) in 100 µL final reaction volume.
Assays were set up by first combining everything except 3H-SAM and microsomes, and
sonicating the mixture until the solution became cloudy due to micelle formation. The
3
H-SAM and microsomes were added, and the reaction incubated at 37°C for 5 min.
Reactions were stopped by adding an equal volume of 10% KOH in methanol, followed
by extraction of hydrocarbon products with 400 µL n-hexane. Aliquots of the hexane
extract were separated by TLC and radioactivity incorporated into the triterpene fractions
determined by scintillation counting. Data is reported as pmoles of methyl groups
transferred to acceptor substrate per unit time and per µg of microsomal protein. Data
represents mean ± S.E.M., n=3.
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Chemical identification of the reaction products

To determine the specific methylation sites on squalene and botryococcene, the monoand di-methylated squalenes and botryococcens produced in vivo by the engineered
yeast were purified and subjected to 1H and 13C NMR analyses. The mono-methylated
squalenes produced by yeast expressing TMT-1, -2, or -3 were all identical based on
their NMR signals and methylated at the C-3 position of squalene (Figure 3.6, compound
2). Similarly, all the di-methylated squalenes produced by all three yeast lines gave
identical NMR signals indicative of methylation at the C-3 and C-22 positions (Figure 3.6,
compound 3). In contrast, the mono-methylated botryococcene produced by yeast
expressing TMT-3 occurred at two positions, either the C-20 position yielding
showacene (Figure 3.6, compound 5) or the C-3 position yielding isoshowacene (Figure
3.6, compound 6). Based on the relative intensity of the NMR signals for the methyl
substituent at C-20 in showacene (compound 5 in Figure 3.6) versus that for C-3 in
isoshowacene (compound 6 in Figure 3.6), showacene accounted for 63% of the total
mono-methylated products. Di-methylated botryococcene produced by TMT-3 was
methylated at the C-3 and C-20 positions (Figure 3.6, compound 7). The very small
amounts of methylated botryococcenes produced in yeast expressing TMT-1 or TMT-2
were not sufficient for NMR analysis; however, the GC-MS patterns of mono-methylated
botryococcene produced by TMT-1, -2, and -3 were all identical (Figure 3.4). These
findings suggest that all the TMT’s methylate botryococcene at identical positions.
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Figure 3.6 Structures of the various triterpenes accumulating in yeast expressing
squalene synthase or botryococcene synthase in combination with TMT-1, -2 or -3.
Yeast expressing the squalene synthase (BSS) gene accumulates squalene (1), and C31
mono-methylated squalene (2) and C32 di-methylated squalene (3) when co-expressed
with the TMT-1, TMT-2, or TMT-3 genes. Yeast expressing the botryococcene synthase
expression cassette (SSL-1-3m) accumulates botryococcene (4), but a mixture of C31
mono-methylated isomers, showacene (5) and isoshowacene (6), and C32 di-methylated
botryococcene (7) when co-expressed with TMT-3. Squalene and botryococcene have
their carbons labeled, and the common sites of methylation are indicated with red
arrows. The mono- and di-methylation sites with the triterpenes that accumulate in the
respective yeast lines are highlighted with red circles. Methylation sites were assigned
according to NMR signatures of the isolated compounds with reference to those
previous reported (20, 60, 74, 75, 76).
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Discussion

The large accumulation of triterpene oils by Botryococcus braunii race B has provided
the impetus for considerable interest in elucidating the biosynthesis of these seemingly
simple molecules. The oil is composed largely of linear, branched-chain triterpenes
resembling squalene, yet the triterpene scaffold, botryococcene, is synthesized by the
successive action of two enzymes rather than a single enzyme like that typical for
squalene biosynthesis (58). While small amounts of the botryococcene and squalene
triterpenes do accumulate, methylated forms of these molecules predominate and
accumulate upwards of 40% of the total algal dry weight. These algae must possess a
robust mechanism(s) for converting the triterpene scaffolds to their methylated forms,
which also lend these molecules to a variety of industrial applications (70).
In the current effort, we identified three triterpene methyltransferases contributing to the
methylation status of botryococcene and squalene, and we were surprised by several of
the biochemical properties uncovered during this investigation. While we identified three
triterpene MTs genes exhibiting sequence similarity to sterol methyltransferases (Figure
3.1), two of these encoded enzymes showed activity and specificity for squalene
methylation. The third TMT appears to have specificity for botryococcene methylation.
The specificity for squalene or botryococcene was unexpected because these molecules
have very similar physical features. Nonetheless, the B. braunii TMTs were found to
discriminate between the two methyl acceptors, as depicted in Figure 3.7, and this must
arise from the ability of the respective enzymes to recognize differences of the internal
linkages within squalene and botryococcene. TMT-3 must be able to recognize the
internal ethyl, methyl substituents at C-10 of botryococcene, while TMT-1 and -2 must
prefer the straight-chain linkage across C-11, -12, -13 and -14 of squalene.
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Figure 3.7 The methyl-triterpene biosynthetic pathways in B. braunii.
SSL-1 converts two FPP molecules to PSPP, which is converted in an NADPHdependent manner to either squalene or botryococcene by SSL-2 or SSL-3,
respectively. TMT-1 and TMT-2 can transfer a methyl group from SAM to squalene to
form mono- or di-methyl squalene, while TMT-3 acts on botryococcene to form mono- or
dimethyl botryococcene.
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The substrate specificity of the TMTs is unexpected when one considers the symmetry
and asymmetry of squalene, botryococcene and the mono-methylated intermediates,
and the successive nature of these catalytic events. Most small molecule MTs catalyze
mono-methylation reactions, with some notable exceptions such as the tri-methylation of
phosphoethanolamine in the biosynthesis of the choline head group in phospholipid
biosynthesis (71). In contrast, the successive methylation of the sterol side-chain at C-24
requires distinct enzymes, sterol methyltransferases 1 and 2 (72, 73.). The successive
nature of the B. braunii TMTs appears to represent yet another permutation in the
activities of this diverse family of enzymes. For TMT-1 and -2, the symmetry of squalene
affords equal probability of methylation at either end of the molecule, but these enzymes
also introduce a second methylation at the equivalent position on the other side of the
molecule. While TMT-1 appears to perform this second methylation with great facility,
this is not the case for TMT-2. The accumulation of di-methylated squalene exceeds
that for mono-methylated squalene greater than 2-fold in yeast expressing the TMT-1
gene (Figure 3.5A), but di-methylated squalene only accumulates to approximately 20%
of that for mono-methylated squalene in yeast expressing TMT-2 (Figure 3.5B). TMT-3
functionally resembles TMT-1 with regards to the ease with which it introduces the
second methylation into the botryococcene backbone, that is, the accumulation of
dimethyl-botryococcene slightly exceded that of monomethyl-botryococcene (Figure
3.5F).
Based on NMR analysis of the mono-methylated botryococcene produced in
yeast, showacene accumulated to higher levels than isoshowacene in an approximate
ratio of 1.7 to 1.0. It is unclear whether this ratio arises from a preference for
methylating botryococcene at the C-20 rather than the C-3 position with both
monomethylated-botryococcenes serving as equal substrates in the second methylation
reaction, or if both the C-3 and C-20 positions of botryococcene are methylated with
equal efficiency but isoshowacene (methylated at C-3) is the preferred substrate for the
second methylation reaction, or a combination of both possibilities. Regardless, the
same 1.7 to 1.0 ratio of showacene to isoshowacene is seen in mono-methylated
botryococcene isolated from B. braunii (73), suggesting that yeast expressing TMT-3
and SSL-1-3m recapitulate the same biochemical bias as observed in B. braunii.
The unique specificities of TMT-1, -2 and -3 offer opportunities to gain insights into
functional aspects of these enzymes. Given the large collection of the class 1 MT crystal
structures and their utility for molecular modeling and mapping residues important for
catalysis in the wider family of MT enzymes, a similar strategy might facilitate identifying
those regions of these Botryococcus MTs specifying substrate selectivity and target site
selection for methylation.
It is important to note that the data provided here is not sufficient to conclude that we
have identified all the mechanisms responsible for in vivo methylation of botryococcene
and squalene in Botryococcus braunii race B. We have identified several genes
encoding for methyltransferases capable of introducing terminal methyl substituents at
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C-3 and C-22/C-20 of squalene and botryococcne. It is also important to point out that
botryococcene and squalene accumulate in B. braunii largely in their tetramethylated
forms. Hence, additional MTs or other mechanisms for the complete methylation pattern
of these triterpenes remain to be discovered.
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Methods

Cloning the SMT-like genes

The triterpene methyltransferase-3 (TMT-3) was identified through a random sequencing
effort of ESTs using a B. braunii phage cDNA library as previously described (58).
Briefly, phages were converted to their plasmid form using the mass excision protocol as
described by the manufacturer (Stratagene), and ~500 individual colonies were
randomly selected for automated DNA sequencing using sequencing primers flanking
the cDNA insertion sites. Manually assembled cDNA sequences were then screened
against the NCBI tBlastn search function across all available databases and TMT-3 was
identified as exhibiting similarity to 24-C-sterol methyltransferase (SMT) genes. All other
SMT-like genes were identified in a B. braunii 454 transcriptomic dataset as previously
described (58). This dataset was screened computationally using a NCBI BLAST search
window with the C. reinhardtii SMT-1 protein sequence (EDP05221) and the Arabidopsis
thaliana SMT-1 sequence (AAG28462) as the queries, which led to the identification of
six full-length ORFs that were at least 42% identical and 59% similar to C. reinhardtii
SMT. Full sequence data is available from Genbank.
Primers flanked by the BamHI and NotI or EcoRI and NotI restriction enzyme sites were
designed to amplify each of the six SMT-like genes from Botryococcus braunii mRNA,
the amplification products digested with the corresponding restriction enzymes, then
ligated into the standard yeast expression vectors YEp352-Ura or pESC-Leu (58). All
constructs were verified by DNA sequencing.
Yeast expression

Yeast lines previously developed for high level accumulation of squalene and
botryococcene were used for evaluating the putative triterpene methyltransferase genes
(22, 41, 58). These lines consist of the TN7 parental strain harboring an insertional
mutation in the native yeast squalene synthase gene (ERG 9) transformed with
expression vectors containing either the full-length Botryococcus squalene synthase
(BSS) gene (37) or a fusion of the Botryococcus SSL-1 and SSL-3 genes (functional
equivalent of botryococcene synthase) including a sequence encoding for the carboxyterminal membrane targeting domain of the Botryococcus squalene synthase protein
(SSL-1-3m) (58). The various methyltransferase expression vectors were introduced into
these two yeast line using the lithium acetate transformation protocol, followed by
selection for complementation of the uracil and leucine auoxtrophic growth markers (41).
Transformants were confirmed to possess the various expression vectors using colony
PCR with primers selective for the methyltransferase genes. Individual colonies were
subsequently grown in 30 mL of the appropriate Yeast Synthetic Drop-out medium
(selection) containing 5 mg/l ergosterol for the indicated time at 30°C before analyzing
the cultures for production of novel triterpene components. In brief, 1 mL aliquots of the
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culture were combined with 1 mL of acetone, mixed vigorously, and incubated at room
temperature for 10 min. One mL of hexane was added and mixed vigorously for 60 sec.
The mixture was then centrifuged briefly at 500 g to separate the phases, and an aliquot
of the hexane (1-3 μL) analyzed by GC-MS with a Varian CP-3800 GC coupled to a
Varian Saturn 2200 MS/MS (Varian Medical Systems) using a Supelco SLB-5ms fused
silica capillary column (30 m x 0.25 mm x 0.25 μM film thickness, Supelco). The initial
oven temperature was set at 220°C for 1 min., ramped to 280°C at 20°C/min., then
ramped to 298°C at 3°C/min.
Purification of mono- and di-methylated triterpenes
Yeast lines containing the respective triterpene synthase and TMT expression cassettes
were grown in 1L Yeast Synthetic Drop-out medium media containing 5 mg/l ergosterol
at 28°C for 8 days, after which hexane extracts were prepared. The crude extracts were
then subject to HPLC separation on a Waters 2695 HPLC with a Waters 2996
Photodiode Array detector (Waters Corporation) and a Develosil 60-3, 250 mm x 20 mm
column (Nomura Chemical), run in isocratic mode (100% n-hexane) at 8 ml/min. Under
these conditions, C32 botrycooccene, C31 botryococcene, C32 squalene, and C31
squalene eluted at ~18, 22, 32, and 34 minutes, respectively.
Repetitive
chromatographic runs afforded further purification of the various compounds.

NMR of methylated triterpenes
1

H and 13C NMR spectra were recorded on a JEOL alpha 600 NMR spectrometer at
300K. Chemical shifts were referenced relative t
H
C
77.1 for CDCl3. Each product was identified as shown in Figure X by referring 13C
chemical shifts for botryococcenes and methylsqualenes previously reported (16, 20, 31,
34, 35).

In vitro assays for the methyltransferase activities
The various B. braunii SMT-like genes or empty vector control were expressed in TN-7
yeast and grown in 100 mL selection media for 3 days, after which microsomes were
prepared according to the methods of Pompon et al. (77). Enzyme assays contained 50
mM HEPES, pH 7.5, either 0.01% (TMT-3) or 0.1% (all other samples) DHPC, 2 mM
acceptor substrate (botryococcene, squalene, C32-botryococcene, C32-squalene,
cycloartenol, zymosterol, or lanosterol), 50 µM 3H-SAM (~150 dpm/pmole), 2 µl
microsomes, in 100 µl total volume. Assays were set up by first combining everything
except 3H-SAM and microsomes and treating with a sonicating water bath (Branson
2510) for ~1 min. until the solution became cloudy due to micelle formation, after which
3
H-SAM and microsomes were added and the reaction incubated at 37°C for 5 min.
Reactions were stopped by adding an equal volume of 10% KOH in methanol, followed
by extraction of hydrocarbon products with 400 µl n-hexane. An aliquot of the hexane
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extract was spotted on silica TLC plates and developed with n-hexane:MTBE (25:1).
Triterpenes were visualized with iodine vapor and the corresponding zones were
scraped and subject to scintillation analysis.

Copyright © Thomas D Niehaus 2011
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Chapter 4 Enzymology of the SSL Enzymes

Introduction
An interesting feature of SSL-2 is that in addition to catalyzing the conversion of PSPP to
squalene, it can also catalyze the formation of bisfarnesyl ether from FPP or FPP and
farnesol. Bisfarnesyl ether catalysis is dependent on NADPH although no reducing
equivalents are formally required. Catalytic constants were determined for bisfarnesyl
ether production by SSL-2 (Km = 57.1µM, kcat = 1.7x10-3/s), which showed that this
activity was nearly 100-fold less efficient than other squalene synthase-like enzymes.
NADPH3 was able to stimulate bisfarnesyl ether biosynthesis consistent with the
NADPH requirement of this reaction being mediated by a structural change in the
enzyme, rather than serving in a catalytic role.
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Background
Based on the observation that B. braunii race B accumulates very little bisfarnesyl ether
or its derivatives, we have assumed that the primary role of the B. braunii SSL-2 enzyme
is to catalyze the conversion of PSPP produced by SSL-1 to squalene (58).
Nonetheless, an unusual and interesting aspect of SSL-2 is its ability to catalyze the
biosynthesis of bisfarnesyl ether from either FPP or FPP and farnesol as substrates (58).
Based on the proposed scheme for bisfarnesyl ether biosynthesis (see Figure 2.8), this
compound may arise from an alternative of the typical squalene synthase-like catalytic
cascade. In squalene synthesis, two molecules of FPP associate with the enzyme. One
of the FPP molecules generates a reactive carbocation species that attacks the second
FPP molecule to form PSPP. If reducing equivalents are present, PSPP can then
undergo a reductive rearrangement to form squalene in an NAD(P)H-dependent manner
(52). In the case of bisfarnesyl ether biosynthesis, the initial ionized FPP is quenched by
a water capture mechanism and the resulting farnesol (FOH) is positioned to react with
the other bound FPP molecule in a Williamson ether synthesis-like reaction to form
bisfarnesyl ether (38).
There have been no prior reports of bisfarnesyl ether accumulation in any organism,
including B. braunii, raising questions about whether this molecule is a true in vivo
metabolite in B. braunii and whether it plays any physiological roles. Because molecular
genetic tools for knocking out gene function or introducing gene silencing constructs are
not available for B. braunii, one must relie on indirect means and correlations to infer the
physiological contribution of an enzyme activity like that for bisfarnesyl ether
biosynthesis by SSL-2. As a first approximation for assessing the in vivo contribution of
SSL-2 towards bisfarnesyl ether biosynthesis, we have sought the catalytic constants for
this enzyme in comparison to the activities of the SSL enzymes found in B. braunii.
Another interesting aspect of bisfarnesyl ether biosynthesis is that this reaction is
NADPH dependent, even though there is no chemical requirement for reducing
equivalents in its proposed biosynthetic scheme. Hence, it is not clear what role(s) this
cofactor might play in the catalytic process. NADPH3, a substrate analogue of NADPH
that is non-hydrolyzable, has previously been shown to stimulate the rate of PSPP
production by squalene synthase. It binds to squalene synthase and induces a
conformational change creating a more catalytic efficient enzyme (15). NADPH3
stimulation of bisfarnesyl ether production by SSL-2 would suggest that nicotinamide
cofactors play a structural rather than catalytic role.
The work presented here describes our efforts to define some of the catalytic constants
of SSL-2 and investigate the role of nicotinamide cofactors in this reaction.
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Results
Bacterial expressed purified SSL-2 was used in enzyme assays to help characterize its
in vitro activity. Initial experiments showed that 30°C was the optimal temperature for
bisfarnesyl ether enzyme activity, with activity dropping off at higher temperatures and
significantly declining at 42°C. All assays described in this chapter were performed at
30°C. Assays were set up with varying pH (Figure 4.1) that showed that activity is
significantly inhibited at pH above 8.0.
Assays set up with varying concentrations of FPP (Figure 4.2) showed that as the
concentration of FPP increases, the ratio of squalene to bisfarnesyl ether formation
increases slightly from about 10% of the total product at 2 µM FPP to about 20% at 80
µM FPP.
The data from Figure 4.2 was used to determine catalytic constants of SSL-2 (Figure
4.3). The Km of FPP for bisfarnesyl ether synthesis was found to be 57.1 µM with a vmax
of 124.8 pmoles/µg/h. The kcat was calculated to be 1.7x10-3/s.
The ability of the nicotinamide cofactors, NADP+, NADPH, and NADPH3 to stimulate
bisfarnesyl ether production were assessed (Figure 4.4). While NADP+ did not stimulate
bisfarnesyl ether production to detectable levels, NADPH3 stimulated ether synthesis to
about 20% the level of NADPH.
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Figure 4.1 Enzyme activity of SSL-2 at varying pH.
Bisfarnesyl ether (blue diamonds) and squalene (red squares) synthase enzyme activity
of SSL-2 with varying pH. Enzyme assays were conducted with 50 mM buffer (acetate
pH 6.0 or Tris pH 6.8, 7.5, 8.0, 9.0, and 9.5), 20 mM MgCl2, 2.5 mM β-mercaptoethanol,
2.5 mM NADPH, 10 µM 3H-FPP (4.8x105 dpm total), and 2 µg bacterial expressed
purified SSL-2 in 50 µl total volume. Reactions were incubated 15 min at 30°C and
stopped by adding 50 µl of 0.5 M EDTA. Reaction products were extracted with 100 µl
MTBE and an aliquot spotted on silica TLC plate with standards of squalene and
bisfarnesyl ether. TLC was developed in n-hexane:MTBE (25:1), standards visualized
with iodine vapor, and the corresponding zones were scraped and subject to scintillation
counting. Data represents mean ± S.D., n=2.
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Figure 4.2 Enzyme activity of SSL-2 at varying FPP concentrations.
Bisfarnesyl ether (blue diamonds) and squalene synthase (red squares) enzyme activity
of SSL-2 with varying concentrations of FPP. Enzyme assays were conducted with 50
mM MOPS, pH 7.3, 20 mM MgCl2, 2.5 mM β-mercaptoethanol, 2.5 mM NADPH, the
indicated concentration of 3H-FPP (4.8x105 dpm total), and 2 µg bacterial expressed
purified SSL-2 in 50 µl total volume. Reactions were incubated 15 min. at 30°C and
stopped by adding 50 µl of 0.5 M EDTA. Reaction products were extracted with 100 µl
MTBE and an aliquot spotted on silica TLC plate with standards of squalene and
bisfarnesyl ether. TLC was developed in n-hexane:MTBE (25:1), standards visualized
with iodine vapor, and the corresponding zones were scraped and subject to scintillation
counting. Data represents mean ± S.E.M., n=3.
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Figure 4.3 Enzyme kinetics of SSL-2.
Data from Figure 4.2 was analyzed using the SigmaPlot Enzyme Kinetics 1.3 module.
Data represents bisfarnesyl ether synthase enzyme activity of SSL-2.

69

30

pmoles/µg/h

25
20
15
10
5
0
0

1

2

3

4

5

6

mM cofactor
Figure 4.4 Effect of nicotinamide cofactors on SSL-2 enzyme activity.
Enzyme activity of SSL-2 with varying concentrations of NADPH (blue diamonds) or
NADPH3 (red squares). Enzyme assays were set up with 50 mM MOPS, pH 7.3, 20
mM MgCl2, 2.5 mM β-mercaptoethanol, the indicated concentration of NADPH or
NADPH3, 10 µM 3H-FPP (4.8x105 dpm total), and 2 µg bacterial expressed purified SSL2 in 50 µl total volume. Reactions were incubated 15 min at 30°C and stopped by
adding 50 µl of 0.5 M EDTA. Reaction products were extracted with 100 µL MTBE and
an aliquot spotted on silica TLC plate with standards of squalene and bisfarnesyl ether.
TLC was developed in n-hexane:MTBE (25:1), standards visualized with iodine vapor,
and the corresponding zones were scraped and subject to scintillation counting. Data
represents mean ± S.E.M., n=3.
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Discussion

The optimal pH for bisfarnesyl ether biosynthesis was observed at pH 6.8, with enzyme
activity decreasing sharply at higher pHs and almost completely lost at pH 9.5 (Figure
4.1). Activity was slightly less at pH 6.0 than 6.8, however it is unclear whether this is
due to a lowering of enzyme activity or a consequence of spontaneous chemical
oxidation of NADPH at lower pH values. For comparison, B. braunii squalene synthase
exhibited only a slight loss of activity at pH 9.5 (data not shown).
The Km of FPP for bisfarnesyl ether biosynthesis by SSL-2 was found to be 57.1 µM with
a kcat of 1.7x10-3/s. For comparison, SSL-1 was shown to have a Km of 12.8 µM and kcat
of 2.7x10-2/s (Figure 2.4). If one compares the catalytic efficiency (kcat/Km) of SSL-1 and
SSL-2, 2.1x10-3/s/M and 3.0x10-5/s/M respectively, SSL-1 is nearly 100-fold more
efficient at converting FPP to PSPP than SSL-2 is at converting FPP to bisfarnesyl ether.
This explains why enzyme assays containing both SSL-1 and SSL-2 accumulate only
squalene and very little if any bisfarnesyl ether (see Figure 2.5H). With SSL-2 having
such low efficiency with FPP as a substrate, it is unlikely that bisfarnesyl ether is
significantly produced in vivo in B. braunii as long as there is sufficient SSL-1 enzyme
present.
Bisfarnesyl ether biosynthesis is dependent on NADPH, but there is no chemical
necessity for why NADPH was needed for this reaction to proceed (see table 2.2).
NADPH may play a structural role when bound to SSL-2, resulting in a conformation
change in the SSL-2 enzyme that makes the SSL-2 enzyme more catalytically
competent for ether formation. However, NADP+ did not stimulate bisfarnesyl ether
production even at concentrations as high as 50 mM. We tested an NADPH synthetic
analogue, NADPH3, for its effect on SSL-2 and found that it stimulated ether
biosynthesis to levels only about 20% of the NADPH stimulation. Because NADPH3 is a
non-hydrolyzable co-factor, we conclude that the nicotinamide cofactors play a structural
role in bisfarnesyl ether production by SSL-2.
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Methods

Enzyme assays

SSL-2 enzyme was expressed in BL21 E. coli and purified as described in the methods
section of chapter 2. Typical enzyme assays were set up with 50 mM MOPS, pH 7.3, 20
mM MgCl2, 2.5 mM β-mercaptoethanol, 2.5 mM NADPH, 10 µM 3H-FPP (4.8x105 dpm
total), and 2 µg bacterial expressed purified SSL-2 in 50 µl total volume, unless
otherwise indicated. Reactions were incubated 15 min. at 30°C and stopped by adding
50 µl of 0.5 M EDTA. Reaction products were extracted with 100 µl MTBE and an
aliquot spotted on silica TLC plate with standards of squalene and bisfarnesyl ether.
TLC was developed in n-hexane:MTBE (25:1), standards visualized with iodine vapor,
and the corresponding zones were scraped and subject to scintillation counting.

NADPH3 synthesis

Synthesis of 12% Pd on BaCO3 catalyst. To 1 g (4.10 mmol, 1.05 equivalents) of BaCl2
in 10 mL of distilled water at 70oC in a 50 mL centrifuge tube was added 8.2 mL of 5%
Na2CO3 solution (3.86 mmol) dropwise over a 15 min period. The mixture was stirred at
70oC for 1 h and centrifuged for 5 min at low speed. The supernatant was decanted. To
the remaining white precipitate was added slowly 0.5 mL of 0.5M PdCl2 in 3.5M HCl
(1.75 mmol of HCl). When gas evolution ceased, 0.5 mL of 37% formalin (Fisher) was
added. The mixture was stirred for 20 h at 25oC to afford a black precipitate. The
mixture was centrifuged, and the aqueous supernatant was discarded. The remaining
catalyst was washed successively with 20 mL portions of water, ethanol and diethyl
ether and was dried in vacuo to afford ca. 500 mg of 12% Pd on BaCO3 catalyst. This
calculated percentage takes into account the BaCO3 neutralized when adding the
PdCl2/HCl solution. The catalyst was used within a week of its preparation in the
following hydrogenation. Commercial samples of Pd on BaCO3 proved ineffectual.
Synthesis of NADPH3. A Lab-Crest pressure reaction vessel (100 mL volume) was
charged with 97 mg of NADP+, 17 mg of ammonium sulfate (130 mg/mmol of NADP+),
188 mg of 12% Pd on BaCO3 catalyst, and 10 mL of cold, distilled water. The tube was
maintained at 0oC until the hydrogenation commenced. The mixture was hydrogenated
in a fume hood at 20 psi H2 at 25oC for 6 h. The mixture was filtered by gravity through
filter paper to afford a clear, pale yellow solution.
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NADPH3 purification

The resulting pale yellow solution from NADPH3 synthesis was filtered at 0.2 µM,
divided into 2 equal aliquots, and lyophilized. The freeze-dried powder from one aliquot
was resuspended in 1 mL of 50 mM NH4HCO3, and loaded on a 10 mL DEAE-Sephadex
A-25 (Sigma) column equilibrated with 50 mM NH4HCO3 and chased with 10 mL 50 mM
NH4HCO3. After completion of the 10 mL chase, a 20 mL gradient from 50 mM to 300
mM NH4HCO3 was run and 1 mL fractions were collected. Afterwards a 20 mL gradient
form 300 mM to 1 M NH4HCO3 was run. The 1 mL fractions were analyzed for
absorbance at 263 and 291 nm, and the fractions corresponding to the peak with the
highest 263/291 nm ratio were pooled and lyophilized. An aliquot of the resuspended
lyophilized product was subject to GC/MS analysis. The purified product had a parent
ion of 748, while NADP+ had a parent ion of 744, confirming the product was indeed
NADPH3.

Copyright © Thomas D Niehaus 2011
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Chapter 5 Identification of a carboxy-terminal, non-catalytic domain of fungal squalene
synthases that is essential for directing squalene flux into the sterol biosynthetic pathway

Introduction

Expression studies of various heterologous squalene synthase genes in S. cerevisiae
corroborated an earlier but surprising observation reported in the literature. While the
squalene synthase gene of S. cerevisiae was able to complement an erg9 (squalene
synthase) knockout in yeast, squalene synthase genes from plants and animals were
not. Chemical profiles revealed that squalene accumulated to significant levels in yeast
expressing the squalene synthase of plant, animal, or S. cerevisiae. Further, squalene
synthase enzyme activity could be detected in lysates from yeast expressing the various
synthases. This suggested that it was not the ability of these heterologous enzymes to
produce squalene, but their inability to feed squalene into the native sterol biosynthetic
pathway that prevented them from restoring normal ergosterol biosynthesis in S.
cerevisiae. The ability of chimera squalene synthase enzymes to complement the erg9
mutation was examined. This led to the identification of a descrete sequence of amino
acids near the C-terminus of the enzyme that is necessary and sufficient for allowing any
squalene synthase to restore normal sterol metabolism.
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Background
The first squalene synthase (SS) gene to be functionally characterized was isolated from
Saccharomyces cerevisiae and cloned concurrently by the Karst and Robinson groups
(78, 79). Both groups utilized the strategy of screening S. cerevisiae genomic library
clones for their ability to functionally complement a squalene synthase (erg9)-deficient
yeast line. Interestingly, Jennings, et al. (79) found that a genomic clone containing only
a partial SS gene fragment was able to restore ergosterol prototrophy even though it
only restored 5% of the normal level of SS enzyme activity. This finding suggested that
low levels of SS enzyme activity were sufficient to complement the erg9 deficiency in
yeast. Soon afterwards, Robinson, et al. (36) attempted to clone the SS gene from
Homo sapiens and S. pombe using the same strategy, but isolated only the S. pombe
gene by screening for complementation of the er9-deficient line (36). Having two SS
genes from two species of fungi, these investigators were able to identify conserved
regions within the deduced protein sequences to which they designed degenerate
primers and cloned the human SS homolog using PCR (36). Robinson, et al. (36)
confirmed that the human squalene synthase gene was unable to restore ergosterol
prototrophy to the erg9-deficient yeast line, but a chimera SS gene constructed by
combining a 5’ region of the human gene containing the putative catalytic domain with a
3’ region of the S. cerevisiae gene containing a membrane-anchoring domain was able
to complement the erg9 deficiency. Robinson, et al. (36) suggested that the inability of
human SS to functionally complement the erg9-deficient yeast line was due to problems
with expression or stability of the human protein in S. cerevisiae. A few years later,
Soltis, et al. (80) isolated a similar allele of the human squalene synthase gene by
screening a human cDNA library with a rat squalene synthase gene probe. These
investigators also determined that the human squalene synthase gene was not able to
complement an erg9 deficiency in yeast. They were, however, able to document
expression of the human squalene synthase gene in yeast by recording the
corresponding protein by immuno-blotting methodology, as well as measuring inducible
enhancement of SS enzyme activity. This result conflicted with the notion that a
heterologously expressed SS was not able to complement the erg9 deficiency in yeast
because of problems with transgene expression or protein stability in yeast, and Soltis,
et al. (80) hypothesized that structural differences in the carboxy-termini of the yeast and
human SS may affect localization or folding of the proteins in association with
intracellular membranes.
The first plant SS was cloned from Arabidopsis (81) and soon after from Nicotiana
benthamiana (82). Nakashima, et al. (81) failed to isolate an Arabidopsis SS gene by
screening for complementation of an erg9 deficient yeast line, and instead screened
plaques of an Arabidopsis cDNA library with a mouse squalene synthase cDNA probe.
Hanley, et al. (82) used a degenerate primer/PCR approach to isolate a N. benthamiana
SS, and likewise noted that the tobacco SS gene was unable to restore growth when
expressed in an erg9 deficient yeast strain. Later, Kribii et al. (83) reported that the
Arabidopsis genome contained two highly homologous SS genes organized in a tandem
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array. This group confirmed that the Arabidopsis SS could not complement the erg9 (SS
gene) disruption in yeast, but they measured significant SS enzyme activity in the
microsomal fraction of these yeast. These investigators went on to show that a chimeric
Arabidopsis SS gene containing a substitution corresponding to the 66 carboxy-terminal
amino acids of Arabidopsis SS with 111 carboxy-terminal amino acids of the S. pombe
SS were sufficient to restore prototrophic growth of the erg9 knockout in yeast without
exogenous sterol. Radiolabeling studies were also performed with [3H]-FPP fed to
microsomes isolated from yeast expressing either the full length Arabidopsis SS or the
Arabidopsis-S. pombe chimera SS genes, or from wild type yeast. Radiolabel was
incorporated by either the wild type yeast microsomes or microsomes from the erg9deficient yeast over-expressing the Arabidopsis-S. pombe chimera SS into squalene,
squalene-2,3-epoxide, and lanosterol. However, when [3H]-FPP was incubated with
microsomes from erg9 deficient yeast expressing the full length Arabidopsis SS, only
radiolabeled squalene was detected. No SS enzyme activity was detectable in the
cytosolic (soluble) fractions of these yeast lines. These results strongly suggested that
active SS was being expressed and targeted to membrane in all the constructs tested;
however, the carboxy-terminal 111 amino acids of S. pombe were necessary for
channeling of squalene into the ergosterol biosynthetic pathway (83).
In 2000, another fungal squalene synthase was isolated from Yarrowia lipolytica using a
degenerate primer approach (84). The Y. lipolytica SS was found to complement an
erg9 deficient yeast line, albeit the complemented yeast grew slower than the yeast
complemented with the S. cerevisiae SS gene. Altogether, this result and those of the
other investigators demonstrated that at least three different fungal SS could
complement the erg9 knockout in S. cerevisiae, but no other SS isolated from animal or
plant could accomplish this task.
In 2008, Busquets, et al. reported that of the two annotated SS genomic sequences in
Arabidopsis, only one coded for a functional SS enzyme (85). Busquets, et al. also
performed some fluorescence microscopy experiments to determine the intracellular
location of Arabidopsis SS. GFP was tagged to the N-terminus of a full length SS, a SS
lacking the equivalent of the carboxy-terminal 67 amino acids, or the GFP was fused
directly to a gene fragment corresponding to that encoding for the carboxy-terminal 67
amino acids of the SS. All three constructs were transiently co-expressed in onion
epidermal cells with an ER-targeted version of DsRed. Both the GFP linked to the full
length SS and the carboxy-terminal 67 amino acids of SS co-localized with DsRed,
which indicated that these two SS enzymes were localized to the ER membrane. The
GFP-SS fusion lacking the carboxy-terminal 67 amino acids appeared localized to only
the cytosol. These authors concluded that the membrane-spanning region at the
carboxy-terminus of SS was critical for correct targeting of SS to the ER membrane (85).
These results and our observations that the algal Botryococcus braunii SS also could not
complement the erg9 mutant in yeast suggested that it was not simply targeting of
squalene synthase enzyme activity to the ER membrane of yeast that was important.
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Some additional protein domain within the carboxy-terminal region of the yeast squalene
synthase was necessary to facilitate the complementation phenotype. The work
reported here represents our efforts to use the erg9 complementation test in yeast to
map a specific peptide domain within the carboxy-terminal region of the yeast squalene
synthase protein necessary for the complementation phenotype.

77

Results

Complementing the erg9 knockout mutation in yeast requires more than active squalene
synthase enzyme activity and squalene accumulation
Various squalene synthases were cloned into the yeast expression vector, Yep352ADH1, including those from S. cerevisiae (YSS), B. braunii (BSS), N. benthamiana
(TSS), A. thaliana (ASS), and R. norvegicus (RSS), as well as a C-terminal truncated
form of YSS in which 24 amino acids comprising the ER membrane-spanning region
were eliminated (YSStr). These constructs were transformed into the yeast line CALI71, which has been selected for high level FPP biosynthesis (41) and has an erg9
knockout mutation. It is unable to synthesize sterols de novo and is dependent on
exogenous ergosterol for growth. To test if introducing the various squalene synthases
could restore ergosterol prototrophy to CALI7-1 yeast line, colonies testing positive for
the respective SS transgene by PCR screens were grown in selection media containing
ergosterol and serial dilutions were spotted on plates not containing exogenous
ergosterol (Figure 5.1). To evaluate the encoded enzymes for catalytic activity, extracts
prepared from the CALI7-1 yeast lines were assayed for squalene synthase enzyme
activity. Constructs were also expressed in TN-7 yeast line and cultures were grown in
liquid media with ergosterol and subsequently analyzed for squalene accumulation.
Squalene levels were determined in TN-7 because in this yeast line, there is no
possibility of squalene feeding into the ergosterol biosynthetic pathway. This allows for
accurate comparisons of squalene production by the various SS enzymes.
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Figure 5.1 Various full length and carboxy-terminally truncated squalene synthases
genes were expressed in yeast line CALI7-1 to test for their ability to complement the
erg9 deletion.
Terminal truncations are indicated by a lack of color in the linear boxed enzyme model
with the specific amino acid coordinates labeled above each. The squalene synthases
tested are those of S. cerevisiae (YSS), B. braunii (BSS), R. norvegicus (RSS), N.
benthamiana (TSS), and A. thaliana (ASS). For the erg9 complementation tests, three
independent CALI7-1 transformants of each construct were randomly selected and
grown in 2 mL Yeast Synthetic Drop-out media (Sigma) containing 5 mg/L ergosterol at
28oC for three days, after which the culture was serially diluted with water to optical
densities (600 nm) equal to 1, 0.2, 0.04, and 0.008, and 5 µL of each dilution spotted
onto Yeast Synthetic Drop-out media plates without any exogenous ergosterol. Plates
were incubated at 28oC for 72 hours. Liquid cultures of each transformant in TN-7 line
were grown in 10 mL of Yeast Synthetic Drop-out media containing 5 mg/L ergosterol at
room temperature for seven days. Organic extracts were prepared and analyzed by GCMS for their squalene content. To validate each gene construct, the squalene synthase
enzyme activity encoded by each gene was assessed when the gene was expressed
Cali-7 yeast. Briefly, 2000 x g supernatants were prepared and used in enzyme assays
containing 3H-FPP and radiolabeled products separated by TLC and analyzed. Enzyme
activity (pmoles/h/µg total protein) is recorded as a percent of YSS. n=3

79

Interestingly, only the full-length YSS gene and a carboxy-terminal truncated form
(deletion of the terminal 24 amino acids) could restore ergosterol prototrophy to the
Cali7-1 yeast line. Further, significant squalene accumulation and SS enzyme activity
was observed in all squalene synthase constructs tested, suggesting that the enzyme
was properly expressed in an active form in all cases (Figure 5.1). This suggested that
all SS enzymes tested properly expressed in vivo, but only YSS could complement the
erg9 deficient CALI7-1 yeast line.

The terminal membrane-spanning domain of squalene synthase is not necessary for
functional enzyme nor complementation of the erg9 mutant
To corroborate and extend the earlier observations of Kirbii et al (83) that a non-catalytic,
carboxy-terminal domain was important for complementation, we created reciprocal
molecular swaps of the terminal 100 or so amino acids of various plant and algae SS
enzymes with that corresponding to the 91 carboxy-terminal amino acids from S.
cerevisiae SS and tested each for its ability to complement the erg9 mutation in yeast
line CALI7-1 (Figure 5.2). As expected, all the constructs that contained the carboxyterminus of S. cerevisiae SS were able to complement the erg9 knockout mutation in
Cali7-1, while none of the S. cerevisiae SS enzymes that had their carboxy-terminus
replaced with that of a plant or algae SS displayed ergosterol prototrophy.
Of equal interest is the observation that constructs containing a deletion of the terminal
24 amino acids of the yeast SS (YSStr, Figure 5.1) or appending this modified terminal
domain to the algal SS (BSS-YSStr, Figure 5.2) did not alter the ability of these gene
constructs to complement the erg9 deletion. On the basis of hydropathy plots of this
region of the SS enzymes (36), this terminal region has been referred to as a
membrane-spanning domain and by inference the domain mediating tethering of the SS
enyzme activity to the ER membrane system in eukaryotic cells (36). Regardless of
these inferences, the YSStr and BSS-YSStr constructs shown in Figs. 1 and 2 encode
for functionally soluble SS enzyme activity (enzyme activity found in 20,000 g
supernatants of E. coli expressing this genes) and these constructs complemented the
erg9 mutation in yeast equally well as the full-length gene constructs. Hence, the
carboxy-terminal 24 amino acids of the yeast SS are not necessary for the
complementation phenotype, but some other element(s) within the proximal 67 amino
acids of the carboxy-terminus appears to be both necessary and sufficient for
complementation.
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Figure 5.2 The carboxy-terminal amino acids of YSS are necessary and sufficient when
appended to heterologous squalene synthase genes to confer ergosterol prototrophic
growth to an erg9 knockout yeast line.
Constructs were created by reciprocal swapping of the DNA sequences coding for the
91 carboxy-terminal amino acids of YSS with the corresponding DNA segments of the
algal (BSS, Botryococcus squalene synthase) and plant (ASS and TSS, Arabidopsis and
tobacco squalene synthase).
An additional 24 amino acid truncation of the YSS
carboxy domain is indicated by a lack of color in the linear enzyme model. Each
construct is annotated with the specific amino acids labeled above each depiction.
Constructs were independently transformed into a yearst erg9 knockout line, and three
independent transformants for each construct were randomly selected for growth in
Yeast Synthetic Drop-out media containing 5 mg/l ergosterol. After three days, each
culture was serially diluted with water to OD600=1, 0.2, 0.04, and 0.008, and 5 µl of
each dilution spotted on Yeast Synthetic Drop-out media plates lacking ergosterol.
Plates were incubated at 28°C for 72 h. Liquid cultures of each transformant in TN-7 line
were grown in 10 mL of Yeast Synthetic Drop-out media containing 5 mg/L ergosterol at
room temperature for seven days. Organic extracts were prepared and analyzed by GCMS for their squalene content. To validate each gene construct, the squalene synthase
enzyme activity encoded by each gene was assessed when the gene was expressed
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Cali-7 yeast. Briefly, 2000 x g supernatants were prepared and used in enzyme assays
containing 3H-FPP and radiolabeled products separated by TLC and analyzed. Enzyme
activity (pmoles/h/µg total protein) is recorded as a percent of YSS. n=3
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Computational screens for possible carboxy terminal domains responsible for the
complementation phenotype
Because squalene synthase genes from S. cerevisiae (this work), S. pombe (36), and Y.
lipolytica (84) have been demonstrated to complement the erg9 knockout in yeast, but
squalene synthases from plant, algae and animals cannot, and because the results in
Figs. 1 and 2 pointed to a proximal carboxy terminal region of 67 amino acids being
responsible for the specificity of this complementation, amino acid sequence
comparisons of this region between relevant squalene synthases were performed. No
over-arching sequence similarities were observed when comparing the sequences
across this region from algae, plants, animals and fungi, although there were greater
similarities within the first 26 amino acids of this region (Figure 5.3A). This degree of
similarity became much more apparent when the alignments of only the fungal squalene
synthase were compared (Figure 5.3B). Within this short segment of amino acids, 8
residues are absolutely conserved and the degree of amino acid similarity across the
entire 26 amino acids reaches upwards of 45%.
To functionally evaluate the contribution of this domain to the complementation
phenotype, reciprocal constructs where these 26 amino acids of YSS were exchanged
with the corresponding amino acids regions within the BSS and ASS were generated.
These constructs were transformed into the erg9 knockout yeast line, and 3 independent
colonies from each transformation were screened for their ability to grow in the absence
of ergosterol (Figure 5.4). When the carboxy-terminal 26 amino acid sequence from S.
cerevisae was substituted into the algal (BSS-YSS-BSS), complementation was readily
apparent. When the carboxy-terminal 26 amino acid sequence from S. cerevisae was
substituted into the Arabidopsis backbone (ASS-YSS-ASS), complementation was
restored but the growth rate was noticeably affected. Further analysis revealed that
squalene accumulation in this yeast line was only about 5% that of the wild type YSS.
Further, squalene synthase enzyme activity in this yeast line was only 7.6% the level as
the YSS-expressing yeast line. This result suggested that the ASS-YSS-ASS was
compromised in its squalene synthase enzyme activity, but was still able to complement
the erg9 knockout. The reciprocal substitutions of inserting the algal or plant amino acid
sequences into the corresponding site of the S. cerevisiae SS resulted in a loss of its
ability to complement the erg9 knockout mutations. The loss of this complementation
capability was not due to a loss in the catalytic activity of the yeast SS. When these
lines were grown in the presence of ergosterol, greater levels of squalene accumulated
in these cultures relative to those lines transformed with the wild type YSS construct or
other erg9 complementing constructs and SS enzyme activity could be readily measured
in yeast lysates.
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A
B.
C.
A.
N.
H.
R.
S.
S.
Y.

braunii
(339)
reinhardtii(331)
thaliana
(331)
benthamiana(329)
sapien
(332)
norvegicus (332)
cerevisiae (339)
pombe
(336)
lipolytica (339)

EVRCNTETSEDPSVTTTLEHLHKIKAACKAGLARTKDDTFDELRSRLLALTGGSFYLAWTYNFLDLRGPG
EAKVDPT---DPSLPLTRQRIAEARKACAAKLTEVSV--------------------------------KTKVDKN---DPNASKTLNRLEAVQKLCRDAGVLQNRKSYVNDKGQP--NSVFIIMVVILLAIVFAYLRA
KSKVNNN---DPNATKTLKRLEVILKTCRDSGTLNKRKSYIIRS-EPNYSPVLIVVIFIILAIILAQLSG
YHRIPDS---NPSSSKTRQIISTIRTQNLPNCQLISRSHYSPIYLSFVMLLAALSWQYLTTLSQVTEDYV
YHRVPNS---DPSASKAKQLISNIRTQSLPNCQLISRSHYSPIYLSFIMLLAALSWQYLSTLSQVTEDYV
KSKLAVQ---DPNFLKLNIQISKIEQFMEEMYQDKLPPNVKPNETPIFLKVKERSRYDDELVPTQQEEEY
HYKNTPK---DPNFLKISIECGKIEQVSESLFPRRFREMYEKAYVSKLSEQKKGNGTQKAILNDEQKELY
YKKSDPN---DPNYFRVSVLCGKIEQHAALIKRQRGPPAKTIAQLEGERKEMALSLIVCLAVIFSMSGLM

B
S. cerevisiae (350) KSKLAVQDPNFLKLNIQISKIEQFMEEMYQDKLPPNVKPNETPIFLKVKERSRYDDELVPTQQEEEY
S. pombe
(347) HYKNTPKDPNFLKISIECGKIEQVSESLFPRRFREMYEKAYVSKLSEQKKGNGTQKAILNDEQKELY
Y. lipolytica (350) YKKSDPNDPNYFRVSVLCGKIEQHAALIKRQRGPPAKTIAQLEGERKEMALSLIVCLAVIFSMSGLM

Figure 5.3 Alignment of the 26 amino acids.
Amino acid alignment of the B. braunii (AF205791), C. reinhardtii (XM_001703395), A.
thaliana (NM_119630), N. benthamiana (U46000.1), H. sapien (NM_004462), and R.
norvegicus (NM_019238) squalene synthases relative to those for S. cerevisiae
(X59959), S. pombe (NM_001021271), and Y. lipolytica (AF092497) (A). The alignment
is limited to the sequences corresponding to the 67 amino acid domain of the S.
cerevisiae squalene synthase that are necessary and sufficient to restore ergosterol
prototrophy to erg9 deficient yeast. The region boxed in red corresponds to a stretch of
26 amino acids that appear more conserved than other regions, and particularly well
conserved amongst the fungal squalene synthase’s (B).
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Figure 5.4 Functional assessment of the role a 26 amino acid peptide sequence within
fungal squalene synthases plays in facilitating the complementation of the erg9 mutant.
Reciprocal constructs were created by swapping the indicated 26 amino acids of the
yeast squalene synthase (YSS) for the corresponding amino acids of an algal squalene
synthase (BSS) and a higher plant squalene synthase (ASS). Three independent Cali-7
transformants for each construct were randomly selected, grown in Yeast Synthetic
Drop-out media (Sigma) containing 5 mg/l ergosterol for three days, after which serial
dilutions were prepared corresponding to optical densities at 600 nm equivalent to 1, 0.2,
0.04, and 0.008, and 5 µl of each dilution spotted onto Yeast Synthetic Drop-out media
plates lacking ergosterol. Plates were incubated at 28˚C for 72 h. Liquid cultures of
each transformant in TN-7 line were grown in 10 mL of Yeast Synthetic Drop-out media
containing 5 mg/L ergosterol at room temperature for seven days. Organic extracts
were prepared and analyzed by GC-MS for their squalene content. To validate each
gene construct, the squalene synthase enzyme activity encoded by each gene was
assessed when the gene was expressed Cali-7 yeast. Briefly, 2000 x g supernatants
were prepared and used in enzyme assays containing 3H-FPP and radiolabeled
products separated by TLC and analyzed. Enzyme activity (pmoles/h/µg total protein) is
recorded as a percent of YSS. n=3
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Mapping the specific amino acids contributing to the complementation phenotype
To further assess the contribution of individual amino acids within this key stretch of 26
amino acids, fine mapping substitution series constructs were generated (Figure 5.5).
First, mutants were created in which either the first half (13 residues) or the second half
of the 26 amino acid domain was swapped from the A. thaliana SS into the S. cerevisiae
backbone (Figure 5.5, mutants a and b). Swapping out the first 13 amino acids of the S.
cerevisiae SS (Figure 5.5, mutant a) had no effect on the ability of the subsequent
construct to complement the erg9 mutation, but swapping the second half resulted in a
complete loss of the complementation phenotype (Figure 5.5, mutant b). Swapping out
the first 13 amino acids of A. thaliana SS with those in S. cerevisiae also had no effect
on the ability of this construct to complement the erg9 mutant (Figure 5.5, mutant f).
However, exchanging the second half of these residues with those of the yeast squalene
synthase enabled the construct to restore partial growth to the erg9 mutant (Figure 5.5,
mutant g). Thus, it appeared that the residues in the second half of the 26-amino acid
domain were largely responsible for complementation phenotype and this stretch of
amino acids was evaluated further.
Because the KIEQ and FLKLNIQ stretches of amino acids seem particularly conserved
amongst the fungal squalene synthases, various combinations of these peptide domains
were exchanged between the ASS and YSS constructs (Figure 5.5, mutants c-e and h-j).
When the “FLKLNIQ” stretch of YSS was replaced with the corresponding domain of
ASS (Figure 5.5, mutant d), complementation growth was not affected, and likewise the
reciprocal swap in ASS (Figure 5.5, mutant i) did not restore complementation.
However, when the “KIEQ” stretch of YSS was replaced with the corresponding domain
of ASS (Figure 5.5, mutant c), growth of the yeast was significantly impaired, suggesting
that complementation had been affected. The reciprocal swap in ASS (Figure 5.5,
mutant h) did not restore growth of the erg9 mutant. Two additional mutants in which the
entire domains spanning from “FLKLNIQ” to “KIEQ” were exchanged (Figure 5.5, mutant
e and j) were also evaluated for their ability to complement the erg9 mutation. Consistent
with our expectations from the other mutants, substituting the yeast amino acids of this
domain with those from the Arabidopsis squalene synthase resulted in a complete lose
in the ability of this construct to complete the erg9 mutation. However, unexpectedly,
substitution of this domain in the Arabidopsis squalene synthase gene with that of the
yeast squalene synthase only restored a very modest level of growth to mutant yeast in
the complementation tests. All constructs tested in Figure 5.5, when expressed in yeast,
accumulated higher levels of squalene and had SS enzyme activity in excess of yeast
expressing YSS.
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Figure 5.5 Evaluating the contribution of a carboxy-terminal sequence of 26 amino acids
conserved amongst fungi to the complementation and restoration of ergosterol
pleiotrophy to an erg9 knockout yeast line.
Full-length S. cerevisiae and Arabidopsis squalene synthase genes were constructed in
which the indicated amino acids corresponding to residues 353 to 378 of YSS and
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residues 345 to 370 of ASS were exchanged with one another in either the YSS gene
(mutants a-e) or the ASS gene (mutants f-j) (in green, ASS amino acids substituted into
the YSS gene; in red, YSS residues substituted into the ASS gene). Each construct was
independently transformed into the Cali7-1 erg9 mutant line, 3 independent
transformants were randomly selected and grown in Yeast Synthetic Drop-out media
(Sigma) containing 5 mg/l ergosterol for 3 days. Aliquots of each culture were then
diluted with water to optical densities (600 nm) corresponding to 1, 0.2, 0.04, and 0.008,
and 5 µl of each dilution spotted on Yeast Synthetic Drop-out media plates lacking
ergosterol. Plates were incubated at 28˚C for 72 h. Liquid cultures of each transformant
in TN-7 line were grown in 10 mL of Yeast Synthetic Drop-out media containing 5 mg/L
ergosterol at room temperature for seven days. Organic extracts were prepared and
analyzed by GC-MS for their squalene content. To validate each gene construct, the
squalene synthase enzyme activity encoded by each gene was assessed when the gene
was expressed Cali-7 yeast. Briefly, 2000 x g supernatants were prepared and used in
enzyme assays containing 3H-FPP and radiolabeled products separated by TLC and
analyzed. Enzyme activity (pmoles/h/µg total protein) is recorded as a percent of YSS.
n=3
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Discussion
While the observation that a non-catalytic, carboxy-terminal domain of the fungal
squalene synthases was important for allowing heterologous squalene synthase genes
to complement a genetic deficiency of squalene synthase (erg9 mutants) in yeast was
noted by several groups of investigators almost 20 years ago (36, 83, 84), the actual
mechanism responsible for this phenomenon has remained unresolved. Kirbii, et al. (83)
suspected that because this carboxy-terminal region of all squalene synthase enzymes
served to anchor the enzymes to membrane systems, the membrane-spanning domain
encompassed by this region of the protein might be important for correctly targeting the
various SS proteins to the ER membrane in yeast, and thus complementing the erg9
deficiency.
Unfortunately, how important the 24 carboxy-terminal amino acids
comprising the membrane-spanning region were for the complementation phenotype
was never tested. Instead, Kirbii, et al. (83) demonstrated that a heterologous squalene
synthase unable to complement the erg9 mutant in yeast could be converted to a
complementing form if its native 67 carboxy-terminal amino acids were replaced with
111 amino acids of the S. pombe SS carboxy-terminus. In the work presented here, we
have demonstrated that the 24 carboxy-terminal amino acids of the native yeast
squalene synthase are not necessary for this enzyme to complement the erg9 knockout
mutation (Figure 5.1), suggesting that the membrane-spanning region may not be as
important for complementation as suggested by Kirbii, et al. (83). In contrast, we have
identified a stretch of 26 amino acids located outside of the membrane- spanning
domain that appear highly conserved to most fungal squalene synthases but not
squalene synthases belonging to animals, plants or other eukaryotic organisms, and
appears sufficient, when appropriately attached to any squalene synthase enzyme, for
the so engineered squalene synthase to complement the erg9 knockout in yeast.
Further mutagenesis and substitution assessment of this 26 amino acid domain revealed
that several of the small stretches of amino acids, especially the KIEQ domain, were
essential for the complementation activity of this domain. Other residues and small
domains distributed across this region could also contribute to the complementation
activity, but these might be more influenced by the context of the surrounding residues.
Altogether, our results suggest that, at least in yeast, it is not the membrane-spanning
region of squalene synthases that is important for establishing ergosterol prototrophy,
but a stretch of amino acids located near the carboxy-terminus that is essential. Our
results also demonstrate that this domain does not influence the catalytic performance of
the squalene synthase enzyme directly, yet must be mediating the complementation
phenotype by some other means.
Although plant and animal squalene synthases were not able to complement the erg9
knockout in yeast, squalene accumulation was readily apparent and was often in vast
excess to the levels observed for the wild type yeast or any of the complemented erg9
mutant lines. Hence, the erg9 mutation cannot be complemented by simple overproduction of squalene. Perhaps it is equally important as to where the squalene might
be produced such that it could feed more directly into the ergosterol biosynthetic
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pathway. Support for this notion comes from the feeding studies performed by Kribii, et
al., in which 3H-FPP was fed to microsomes from yeast expressing either ASS (noncomplementing the erg9 mutant) or an ASS-YSS fusion (complementing). With the
ASS microsomes, 3H-labeled squalene was the only detectable metabolite. However,
with the ASS-YSS microsomes, radiolabel was also found in squalene epoxide and
lanosterol, two reaction intermediates downstream of squalene in the ergosterol
pathway. Equally interestingly, nearly all the squalene synthase enzyme activity
reported for these independently transformed lines was associated with the microsomes,
indicative that the squalene synthases seem to be correctly targeted to the ER
membrane.
How then can SS enzymes targeted to the correct membrane system (i.e. the ER) still
be active and generating squalene, yet the squalene produced doesn’t seem sufficient to
complement the erg9 mutation? Perhaps the simplest explanation is that the squalene
biosynthesized under these conditions is not in the right subcellular environment to be
properly channeled into sterol metabolism. Such a notion would be consistent with the
carboxy-terminal located 26 amino acid domain essential for complementation playing
some role in protein:protein interactions and, thus possibly serving to insert the squalene
synthase enzyme activity into the right environment and context for the channeling of
squalene onto the next enzymes in the sterol biosynthetic pathway. The identification of
ERG28 as a protein scaffold that directly influences the efficiency of sterol biosynthesis
by coordinating the interaction between enzymes in the sterol biosynthetic pathway (86)
provides a compelling example for our suggestion here.
The stretch of 26 amino acids is well conserved among fungal squalene synthases, and
particularly the KIEQ sequence is strongly conserved. For example, the fungal species
Kluyveromyces lactis, Candida glabrata, Pichia jadinii, and Botryotinia fuckeliana all
share greater than 50% identity to the S. cerevisiae 26 amino acid domain and the KIEQ
sequence is completely conserved. Other fungal species such as Zygosaccharomyces
rouxii, Clavispora lusitaniae, and Aspergillus clavatus share greater than 50% identity
within the 26 amino acid domain but contain a similar RIEQ instead of KIEQ sequence.
If this stretch of amino acids is vital for proper sterol biosynthesis in other fungi, as it is in
S. cerevisiae, then peptides or small molecules that block or mimic these residues could
disrupt sterol metabolism. Such molecules could potentially be used as fungal specific
antibiotics.
Another important question arising from the current observations is if analogous domains
to the 26 amino acid stretch identified here in the yeast squalene synthase also exists in
other squalene synthases, like that for man? If so, then blocking the protein:protein
interactions that such a squalene synthase might participate in could disrupt the flow of
squalene to the sterol biosynthetic pathway and thus represent in a novel mechanism to
regulate cholesterol in man. There are now good examples of drugs targeting proteinprotein interactions such as anti-tumor and anti-cancer drugs. Brooks et al. (87) showed
that MMP2 binding to the αVβ3 integrin played a major role in the process of
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angiogenesis, but that the interaction of these proteins could be blocked with a small
peptide fragment of MMP2. Using a combinatorial chemistry approach, they also
identified a small molecule that could block these protein-protein interactions in a dosedependent manner, and demonstrated that these same small molecule blocked tumor
growth in in vivo model studies.
In conclusion, we have shown that a stretch of 26 amino acids near the carboxyterminus of fungal squalene synthase is both necessary and sufficient for any squalene
synthase to restore ergosterol prototrophy to erg9 deficient yeast, and that the function
of this stretch of amino acids is not likely involved in correctly targeting squalene
synthase to the ER membrane, but instead may play a role in metabolon assembly of
sterol biosynthetic proteins.
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Methods

Cloning the various squalene synthases
Squalene synthases from S. cerevisiae (YSS), B. braunii (BSS), R. norvegicus (RSS), N.
benthamiana (TSS), and A. thaliana (ASS) were cloned from original cell or tissue
sources. First, total RNA was isolated from the respective species using the RNeasy
Plant mini kit (Qiagen) or Trizol (Invitrogen, for R. norvegicus and S. cerevisiae)
according to the manufacturers recommendations, and first strand cDNA was
synthesized using the SMARTer PCR cDNA synthesis kit (Clontech). The first strand
cDNA was used as a template to amplify the various squalene synthase genes using the
primer sets listed in Table 5.1 (restriction site in bold). YSS was cloned into the Yep352
vector with the AscI and XbaI sites, and a 3’-truncated form cloned into Yep352 and
pET28a using the AscI and XbaI or BamHI and XhoI sites, respectively. BSS and its 3’truncated form were cloned into Yep352 with the EcoRI and HindIII sites. A 5’- and 3’truncated RSS was cloned into Yep352 and pET28a using the EcoRI and HindIII sites or
BamHI and XhoI sites, respectively. TSS was cloned into Yep352 with the EcoRI and
NotI sites and its 3’-truncated form was cloned into Yep352 and pET28a with the EcoRI
and NotI sites. ASS was cloned into Yep352 with the EcoRI and NotI sites. All
constructs were verified by automated DNA sequencing.
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Table 5.1 Squalene Synthase Primer Sequences.
gene
YSS

BSS

RSS

TSS

ASS

primer
AscI For
BamHI For
XbaI Rev
NotI Rev
XbaI Rev trunc
XhoI Rev trunc
NotI Rev trunc
EcoRI For
HindIII Rev
NotI Rev
HindIII Rev
trunc
EcoRI For
trunc
BamHI For
trunc
HindIII Rev
trunc
XhoI Rev trunc
EcoRI For
XbaI Rev
NotI Rev
NotI Rev trunc
EcoRI For
XbaI Rev
NotI Rev

Sequence
AGGCGCGCCAAAACAATGGGAAAGCTATTACAATGGC
CGCGGATCCAAAACAATGGGAAAGCTATTACAATGGC
GCTCTAGATCACGCTCTGTGTAAAGTGTATAT
ATAAGAATGCGGCCGCTCACGCTCTGTGTAAAGTG
GCTCTAGATCACTTGTACTCTTCTTC
GGGCTCGAGTCACTTGTACTCTTCTTC
ATAAGAATGCGGCCGCTCACTTGTACTCTTCTTCTTG
CCGGAATTCAAAACAATGGGGATGCTTCGCTGGGGAGTGG
ATCCCAAGCTTTTAGGCGCTGAGTGTGGGTCTAGG
ATAAGAATGCGGCCGCTTAGGCGCTGAGTGTGGGTCTAGG

CCCAAGCTTTCACCACCAATGTTGGGTTACAGA

CCGGAATTCAAAACAATGGACCGGAACTCGCTCAGC

CGCGGATCCATGGACCGGAACTCGCTCAGC

CCCAAGCTTTCAGCTCTGCGTCCTGATGTTGGAG
CCGCTCGAGTCAGCTCTGCGTCCTGATGTTGGAG
GGAATTCATGGGGAGTTTGAGGGCTATTC
GCTCTAGACTAAGATCGGTTTCCGGATAGC
ATAAGAATGCGGCCGCCTAAGATCGGTTTCCGGATAGC
ATAAGAATGCGGCCGCTCAGTAATTAGGCTCGCTCCTG
CCGGAATTCAAAACAATGGGGAGCTTGGGGACGATGCTG
GCTCTAGATCAGTTTGCTCTGAGATATGC
ATAAGAATGCGGCCGCTCAGTTTGCTCTGAGATATGCAAAG

Creating the BSS-YSS fusion
A reverse primer was designed to pair with the BSS EcoRI For (see Table 5.1), to
amplify the first 352 codons of BSS except that a single nucleotide mutation was
introduced into the 352nd codon to introduce a HindIII restriction site without changing
the encoded amino acid (ATCCCAAGCTTCTCTGCTAATTTGAGG, HindIII site in bold,
mutation underlined). This was cloned into the pET28a vector with the corresponding
restriction sites, giving BSS352-pET28a. Another primer was designed to pair with either
primer, YSS NotI Rev or YSS NotI Rev trunc, to amplify YSS starting from codon 353
(ATCCAAGCTTAAATCTAAATTGGCTGTGC, HindIII site in bold), and these fragments
cloned into BSS352-pET28a cut with HindIII and NotI to give the BSS-YSS and BSS93

YSStr constructs. These were cut from the pET28a vector using EcoRI and NotI and
ligated into the corresponding sites of Yep352. The construct was verified by automated
DNA sequencing.

Creating the BSS-YSS-BSS expression cassette
A primer was designed to pair with primer, BSS EcoRI For, to amplify a fragment of the
BSS-YSS
construct
with
NgoMIV
and
NotI
restriction
sites
(ATAAAGAATGCGGCCGCGAATGCCGGCTTCCATAAACTGTTCGATCTTGG,
NgoMIV and NotI sites in bold). This was cloned into the EcoRI and NotI sites of
YEp352, which was later cut with NgoMIV and NotI. Meanwhile a primer was designed
to pair with primer, BSS NotI Rev, to amplify a 3’ region of BSS except that two
nucleotide mutations were introduced to add an NgoMIV restriction site without changing
the
encoded
amino
acids
(GCAAAGAATGCCGGCCTGGCACGCACAAAAGATGACACC, NgoMIV site in bold,
mutations underlined). This fragment was cloned into the NgoMIV and NotI sites of the
cut Yep352 vector to give BSS-YSS-BSS. The construct was verified by automated
DNA sequencing.

Creating other fusion constructs
All other fusion constructs were created by employing an assembly PCR strategy as
described by Niehaus et al. (58), using the primers listed in Tables 1 and 2. For
example, YSS-BSS was created by using YSS as a template with the primer set, YSSBSS 1R and YSS AscI For, to amplify a fragment of YSS with a 3’ overhang, and using
BSS as the template with the primer set, YSS-BSS 1R and BSS HindIII Rev, to amplify a
fragment of BSS with a 5’ overhang. These two fragments were both used as templates
in a PCR reaction with the primer set, YSS AscI For and BSS HindIII Rev, to give the
YSS-BSS construct, which was cloned into the YEp352 vector with the corresponding
restriction sites. YSS-BSS-YSS was created by using YSS-BSS and YSS as templates
in the initial PCR reaction, and cloning the finished construct into YEp352 with the AscI
and XbaI sites. All other constructs were created in a similar manner. TSS-YSS and
YSS-TSS were cloned into YEp352 with the EcoRl and NotI, or AscI and XbaI restriction
sites, respectively. YSS-ASS and ASS-YSS were cloned into YEp352 with AscI and
XbaI, or EcoRI and XbaI restriction sites, respectiviely. All YSS M(a)-M(e) constructs
were cloned into YEp352 with the AscI and XbaI restriction sites, and all ASS M(f)-M(j)
constructs were cloned into YEp352 with EcoRI and XbaI restriction sites. All constructs
were verified by automated DNA sequencing.

94

Table 5.2 Chimeric Squalene Synthase Primer Sequences.
construct

direction

sequence

YSS-BSS

1F

CTTACGTGATATCGAAGTCAGATGCAACACCGAGACCAGCGAGGATCCC

1R

GCATCTGACTTCGATATCACGTAAGTAATAGTCAAAAATCTCGACACAGCC

1F

CTTACGTGATATCAAGACAAAGGTTGACAAGAACGATCCAAATGCCAG

1R

CAACCTTTGTCTTGATATCACGTAAGTAATAGTCAAAAATCTCGACAC

1F

CCTGCATGCTGAAATCTAAATTGGCTGTGCAAGATCCAAATTTCTTA

1R

GCCAATTTAGATTTCAGCATGCAGGAAAAATCATAGAAAGCACCATAG

1F

CTTACGTGATATCAAATCCAAGGTTAATAATAATGATCCAAATGCAAC

1R

TTAACCTTGGATTTGATATCACGTAAGTAATAGTCAAAAATCTCGACAC

1F

GACTTTTCTTGTATGCTGAAATCTAAATTGGCTGTGCAAGATCCAAATTTCTT

1R

GCCAATTTAGATTTCAGCATACAAGAAAAGTCAAAAAAAGCACCATATACATC

1F

CAAAGCTGCCTGCAAGGAAATGTACCAGGATAAATTACCTCCTAACGTGAAGCC

1R

CCTGGTACATTTCCTTGCAGGCAGCTTTGATCTTATGCAGGTGTTCCAGAG

1F

AAGACAAAGGTTGACAAGAACGATCCAAATGCCAGTAAGACACTAAACCGACTTGAAGCC

1R

TCTGCAGAGTTTCTGAACGGCTTCAAGTCGGTTTAGTGTCTTACTGGCATTTGGATCGTT

1F

AAATCTAAATTGGCTGTGCAAGATCCAAATTTCTTAAAATTGAACATTCAAATCTCCAAG

1R

TTCCATAAACTGTTCGATCTTGGAGATTTGAATGTTCAATTTTAAGAAATTTGGATCTTG

1F

CTCCGCCGTTCAAAAGTTTATGGAAGAAATGTACCAGGATAAATTACC

1R

CCATAAACTTTTGAACGGCGGAGATTTGAATGTTCAATTTTAAG

1F

AATGCCAGTAAGACACTAAACCGTATCTCCAAGATCGAACAGTTTATGG

1R

GATACGGTTTAGTGTCTTACTGGCATTTGGATCTTGCACAGCCAATTTAG

1F

GCCAGTAAGACACTAAACCGTCTTGAAGCCGTTCAGAAGTTTATGGAAGAAATGTACCAG

1R

CTTCTGAACGGCTTCAAGACGGTTTAGTGTCTTACTGGCATTTGGATCTTGCACAGCC

1F

AAGACAAAGGTTGACAAGAACGATCCAAATGCCAGTAAGTTGAACATTCAAATCTCCAAG

1R

CTTACTGGCATTTGGATCGTTCTTGTCAACCTTTGTCTTGATATCACGTAAGTAATAGTC

1F

ACACTAAACCGACTTGAAGCCGTTCAGAAACTCTGCAGAGAAATGTACCAGGATAAATTA

1R

TCTGCAGAGTTTCTGAACGGCTTCAAGTCGGTTTAGTGTTTTTAAGAAATTTGGATCTTG

YSS-ASS

ASS-YSS

YSS-TSS

TSS-YSS

YSS-BSS-YSS

YSS-ASS-YSS

ASS-YSS-ASS

YSS M(c)

YSS M(d)

YSS M(e)

YSS M(a)

YSS M(b)

ASS M(h)

1F
1R

ASS M(i)

ASS M(j)

ASS M(f)

ASS M(g)

1F

AATTTCTTAAAATTGAACATTCAACTTGAAGCCGTTCAGAAACTCTGCAG

1R

AAGTTGAATGTTCAATTTTAAGAAATTTGGATCGTTCTTGTCAACCTTTG

1F

TTCTTAAAATTGAACATTCAAATCTCCAAGATCGAACAGCTCTGCAGAGACGCTGGAG

1R

CTGTTCGATCTTGGAGATTTGAATGTTCAATTTTAAGAAATTTGGATCGTTCTTGTCAAC

1F

AAATCTAAATTGGCTGTGCAAGATCCAAATTTCTTAAAAACACTAAACCGACTTGAAGCC

1R

TTTTAAGAAATTTGGATCTTGCACAGCCAATTTAGATTTCAGCATGCAGGAAAAATCATA

1F

TTGAACATTCAAATCTCCAAGATCGAACAGTTTATGGAAGACGCTGGAGTTCTTCAAAAC

1R

TTCCATAAACTGTTCGATCTTGGAGATTTGAATGTTCAACTTACTGGCATTTGGATCGTT
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The erg9 complementation assay
The Cali7-1 yeast line, which has an erg9 deletion so that it cannot synthesize sterols de
novo and requires exogenous ergosterol for growth, was used for these purposes (41).
The various squalene synthase constructs were transformed into Cali7-1 yeast using the
lithium acetate method and plated on Yeast Synthetic Drop-out medium (selection
media) lacking uracil and containing 5 mg/l ergosterol. Three independent CALI7-1
transformants of each construct were randomly selected and grown in 2 mL Yeast
Synthetic Drop-out media (Sigma) containing 5 mg/L ergosterol at 28oC for three days,
after which the culture was serially diluted with water to optical densities (600 nm) equal
to 1, 0.2, 0.04, and 0.008, and 5 µL of each dilution spotted onto Yeast Synthetic Dropout media plates without any exogenous ergosterol. Plates were incubated at 28oC for
72 hours.
Liquid cultures of each transformant in TN-7 line were grown in 10 mL of Yeast
Synthetic Drop-out media containing 5 mg/L ergosterol at room temperature for seven
days. Organic extracts were prepared and analyzed by GC-MS for their squalene
content. In brief, 1 mL aliquots of the culture were combined with 1 mL of acetone,
vigorously mixed, and incubated at room temperature for 10 min. One mL of hexane was
added and mixed vigorously for 60 sec. The mixture was then centrifuged briefly at
500xg to separate the phases, and an aliquot of the organic phase removed and 1-2 μL
aliquots analyzed by GC-MS with a Varian CP-3800 GC coupled to a Varian Saturn
2200 MS/MS (Varian Medical Systems) using a Supelco SLB-5ms fused silica capillary
column (30 m × 0.25 mm × 0.25 μM film thickness, Supelco). Initial oven temperature
was set at 220 °C for 1 min., ramped to 280 °C at 20 °C/min., then ramped to 300 °C at
3 °C/min.
The various SS constructs were expressed in Cali-7 yeast and grown for 3 days before
1.5 ml of culture was collected by centrifugation and stored at -80C until further
analysis. Yeast pellets were resuspended in 0.5 ml buffer (50 mM NaH2PO4, pH 7.8,
300 mM NaCl, 1 mM MgCl2, 1 mM PMSF, 1% glycerol (v/v)) then sonicated 3 x for 5 sec
with a microprobe sonicator at 60% maximum power. The samples were cooled on ice
for 2 min between sonication treatments. The sonicate was centrifuged at 2,000 g for 10
min at 4°C and the supernatant used in enzyme assays. Assays contained 50 mM
Mops, pH 7.3, 20 mM MgCl2, 2.5 mM 2-mercaptoethanol, 10 μM [1-3H]-FPP (~1x105
dpm total), and 2 mM NADPH in total reaction volume of 50 μL. Reactions were
incubated at 37ºC for 1 h and then extracted with 100 µl n-hexane and an aliqout spotted
on TLC with a squalene standard. TLC was developed with n-hexane and the squalene
zone was scraped and analyzed by scintillation spectroscopy. The amount of total
protein in the yeast supernatants was determined by Bradford Dye assays. Enzyme
activity (pmole/h/µg total protein) is expressed as a percent of S. cerevisiae squalene
synthase (YSS) enzyme activity. n=3.
Copyright © Thomas D Niehaus 2011
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Chapter 6 Concluding Remarks
Chapter 2 describes the pathway for botryococcene biosynthesis in B. braunii which is
interesting because new mechanisms for botryococcene and squalene catalysis are
suggested. Squalene biosynthesis in other organisms has been well documented,
consisting of in initial condensation of 2 molecules of FPP to form PSPP, then an
NAD(P)H dependent reductive rearrangement of PSPP to form squalene. Both of these
steps occur within a single enzyme unit, and this mechanism is highly conserved
amongst all eukaryotes. In contrast, B. braunii seems to have evolved completely
different mechanisms for botryococcene and squalene formation. First, the enzyme
SSL-1 catalyzes the condensation of 2 molecules of FPP to form PSPP as its sole
reaction product. Two additional enzymes, SSL-2 and SSL-3, cannot use FPP as a
substrate but instead are able to reductively rearrange PSPP generated by SSL-1 to
form squalene or botryococcene, respectively. With this new suite of squalene
synthase-like enzymes available which are specialized in one particular half-reaction,
one can predict specific residues that may be important for particular steps in the
reaction cascade and test these predictions with mutagenesis experiments. Thus these
enzymes will greatly facilitate the understanding of the squalene synthase enzymology;
which has remained vague despite decades of study.
Through biochemical studies of the SSL enzymes described in chapter 2 it was
discovered that SSL-2 catalyzed the formation of bisfarnesyl ether from either FPP or
FPP and farnesol as substrates. Bisfarnesyl ether is an unusual molecule that has
never been reported to accumulate in any organism, including B. braunii, and likely
results from a perturbation of the normal catalytic cascade of the SSL-2 enzyme.
Chapter 4 describes some of the kinetic parameters and cofactor requirements for
bisfarnesyl ether catalysis by SSL-2. This information could aid in studies aimed at
understanding the enzymology of squalene synthase-like enzymes. Additionally, the
NADPH3 that was synthesized for this work may also be used in crystallography studies
of the SSL enzymes to determine how nicotinamide cofactors interact with such proteins.
Chapter 2 also describes the production of botryococcene in a yeast heterologous host.
Expression of SSL-1 and SSL-3 on separate plasmids caused a modest accumulation of
botryococcene in yeast, however, fusing these two peptides with a short amino acid
linker and adding a peptide sequence at the carboxy terminus that targeted to yeast ER
membrane caused accumulation to increase 5-fold, demonstrating that high levels of
botryococcene can be produced in a heterologous host. However, for this high-value oil
to be produced in a clean, renewable, and sustainable means, this pathway will have to
be engineered in a photosynthetic organism capable of converting atmospheric CO2 into
botryococcene, such as fast growing plants or algae. Efforts to deploy high level
botryococcene biosynthesis in a photosynthetic platform will benefit from the examples
shown in yeast.

97

Triterpene methyltransferases (TMTs) that can introduce methyl groups to either
squalene or botryococcene are described in Chapter 3. These TMTs are capable of
converting the C30 triterpenes into more highly branched C32 forms, thus increasing
there efficacy as petrochemical feedstocks. It was demonstrated that high levels of
methylated triterpenes accumulated in yeast expressing TMT’s along with triterpene
synthases. Attempts to produce triterpenes in photosynthetic organisms should also
include the TMTs described in chapter 3 to produce an optimal feedstock for fuel
production. These TMT genes also offer an opportunity to further dissect substrate
specificity and methylation target site selectivity.
Chapter 5 describes a specific stretch of amino acids that are necessary and sufficient to
allow any squalene synthase to functionally complement an erg9 (squalene synthase)
deficient yeast line by allowing squalene to feed into the sterol biosynthetic pathway.
This represents a nice example of metabolon assembly and increases our
understanding of sterol metabolism. Additionally, these studies could lead to future drug
design. For example, small molecules could be designed that mimic the specific stretch
of amino acids and block yeast squalene synthase from forming a metabolon, thus
disrupting sterol biosynthesis in yeast. Such drugs could be used to specifically target
yeast or other fungal pathogens. Also interesting, does this phenomenon of a specific
stretch of amino acids of squalene synthase being necessary to feed squalene into the
sterol biosynthetic pathway occur in other organisms besides yeast? The work in
chapter 5 warrants studies to see if similar mechanisms occur is plants and animals. If
this mechanism is conserved across Kingdoms, then it could lead to a new class of
cholesterol lowering drugs in human.

Copyright © Thomas D Niehaus 2011
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